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Abstract 
Latinos of low socioeconomic status are disproportionately affected by diabetes Type II 
complicated by poor adherence to diabetes Type II medications and management 
programs. Self-management of diabetes Type II is a tool used to teach health education to 
patients with diabetes. The objective of this retrospective quantitative study was to 
explore if there are predictors of nonadherence to diabetes Type II medications and 
programs among Latinos with diabetes Type II.  Data from 200 patient records from a 
community clinic in Fresno County California were analyzed using both bivariate and 
multivariate analysis. Selected sociodemographic independent variables were age, 
gender, income, migrant worker status, family size, and having received health education. 
The dependent variable was adherence to medication and management programs. Gender 
and health education were the only strong predictors of nonadherence to diabetes Type II 
medications and programs among the study sample in the bivariate analysis. The 
combination of gender and health education was the only strong predictor to diabetes 
Type II medications and programs in the multivariate analysis. Recommendations include 
personalized health education that incorporates a protocol for teaching patients about diet, 
consumption of alcoholic beverages, exercise, medication, and the effects these behaviors 
have on diabetes prevention and management. The implications for positive change 
include decreasing complications, improving quality of life, and improving patient 
satisfaction. The implications also include decreasing health care cost for stakeholders, 
including patients, and insurance payers. 
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Chapter 1: Introduction to the Study  
 According to Fonseca, Kirkman, Darsow, and Ratner (2012), nearly 26 million 
people in the United States have diabetes Type II. Fonseca et al. found that 25% of the 
population ages 25 and older have diabetes or are prediabetic. Furthermore, Gerber 
(2010) found that diabetes Type II medication nonadherence, which is the cause for many 
diabetes Type II complications, is high among Latinos, including migrant workers. The 
National Diabetes Education Program (2007) reported that a cardiovascular disease is a 
problem for persons with diabetes Type II, leading to disability and early death. The 
National Diabetes Education Program added that 65% of individuals with diabetes Type 
II die from coronary artery disease and stroke.   
Horton (2012) described persons with diabetes Type II as having complications 
that socially impact society. This impact is multifactorial from diabetes Type II 
complications, medication nonadherence, depression, no access to health care, increased 
emergency room visits to hospitalizations from hyperglycemia, and macro vascular 
atherosclerotic cardio vascular disease. However, the Latino patient who better adheres to 
diabetes Type II medications may experience fewer complications. A Type II patient’s 
quality of life may improve if he or she complies with medication requirements, 
decreasing emergency room visits and hospitalizations. Latinos have a higher opportunity 
for severe complications impacting their daily life, work, home, and social environment. 
Thus this, study provides information regarding management of diabetes Type II for the 
migrant worker who moves from one state to another in search of work. Teaching these 
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patients how to best manage their diabetes Type II with diet, exercise, regular 
medications, and how to access resources is a predictor that needs to be explored. 
Chapter 1 is divided into 11 sections. Each section provides pertinent information 
regarding the different topics. The introduction and background contains literature related 
to the impact of diabetes Type II. In the problem statement and purpose of the study, I 
discuss the problem being addressed and the intent of the study. I explain the research 
question and hypothesis as well as the null and the alternative hypothesis for each 
variable and for the research question. The theoretical and conceptual framework for the 
study provides information regarding the theories, and I explain how the theory relates to 
the study. The nature of the study provides information regarding the reason for choosing 
the method and study design. The definition includes the definitions of the independent 
variables as well as the dependent variables. Assumptions are used to clarify 
characteristics of the study that are considered part of the Latinos diabetes Type II beliefs 
but cannot be described in a true statement. A summary and conclusion close the chapter 
with themes and how the study fills the gap in the literature.  
Background 
Cusi and Ocampo (2011) reflected on the importance of health care providers 
being aware of the need for individualized intervention plans for the Latino patient. 
Awareness of patients’ needs, cultural beliefs, and socioeconomic and 
socioenvironmental barriers is important in order to plan interventions appropriate for the 
patient. According to Cusi and Ocampo, a gap exists between ethnic/minorities in the 
United States, with obesity and being overweight affecting more Latinos than Whites. 
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Latinos with diabetes Type II poorly manage their disease and have a higher incidence of 
hyperglycemia, high blood pressure, and elevated hyperlipidemia (Cusi & Ocampo, 
2011). Latinos are also at a disadvantage as compared to Whites with more 
cardiovascular disease and socioeconomic barriers, such as language, cost, and access to 
resources, including health care (Cusi & Ocampo, 2011). In 2009, Latinos had a higher 
prevalence of diabetes Type II as opposed to White patients; the prevalence of diabetes 
Type II for Latinos was 11.8% as opposed to 7.1% for Whites (Cusi & Ocampo, 2011). 
The predictors of this study were used to determine if there was an association among 
Latinos with diabetes Type II nonadherence and adherence to medications. Cusi and 
Ocampo recommended further studies relating to barriers that impact the Latino 
community with diabetes Type II to improve the social impact, cost, disability, and even 
death from complications. Hence, improving positive outcomes ought to be the goal for 
clinicians and physicians. Adherence to medication, diet, and exercise are the triad for 
better diabetes Type II outcomes. 
Chan (2010) stated that medication nonadherence to medication regimens is a 
health problem impacting the individual, family, community, and resources. Chan 
estimated that nonadherence is responsible for approximately $100 billion a year in 
health care costs. Therefore, health education is important not only by the health 
educators but by the health care providers as well to improve diabetes Type II adherences 
to medications (Chan, 2010). 
The Centers for Disease Control and Prevention (CDC, 2011) noted that, in the 
United States, the direct expense for diabetes Type II in 2007 was $116 billion for 
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medical expenses and $58 billion for disability, work loss, and premature death. The 
CDC reported on complications such as heart disease as the cause of death in 68% of 
diabetes-related deaths. Stroke was noted to be 16% of diabetes-related deaths.  Other 
complications self-reported by patients with diabetes Type II included 67% with 
hypertension and diabetes. Moreover, blindness and eye problems were seen in 
individuals between 20 and 74 years. The CDC reported that between 2005 and 2008, 4.2 
million patients had some type of eye problem when they were examined and found that 
655,000 diabetes Type II patients age 40 and older had a serious type of diabetic 
retinopathy. The CDC reported that in 2008, there were 202,290 diabetics with end-stage 
kidney disease living with regular dialysis or kidney transplant. Additionally, nervous 
system diseases were found among 60% to 70% of patients with Type II diabetes, 
including carpal tunnel syndrome, impaired sensation of lower extremities, and erectile 
dysfunction. 
Wroth and Pathman (2006) noted that, regardless of the number of studies done, 
Latinos’ nonadherence to diabetes Type II medications continues to be a problem, and 
little is known about why patients failed to follow clinicians’ recommendations. Smith 
(2009) pointed out that Afro-Caribbean and Latino descent patients are at a higher risk of 
diabetes Type II, and a gap still exists in relation to sociodemographics and diabetes Type 
II affecting Latinos. In their database research relating to diabetes Type II and racial 
ethnic minorities, Peek, Cargill, and Huang (2007) found that two-thirds of the studies 
were controlled trials or randomized controlled trials. Therefore, Peek et al. proposed that 
more studies are needed relating to patients with diabetes Type II of racial, ethnic 
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minority groups. The specific characteristics ought to relate to the patient’s 
sociodemographics, education, and other variables that relate to the patient’s 
socioenvironment. 
Thus, this study was needed to understand Latinos with diabetes Type II 
nonadherences to medications, taking into consideration age, income, health education, 
migrant worker status, family size, and gender. Understanding the predictors of 
nonadherence affecting the Latino community is important to provide primary prevention 
services to prevent new cases of diabetes Type II (Issel, 2009). Secondary prevention 
includes providing screening to detect early cases of prediabetes or diabetes Type II and 
teaching individuals to live with diabetes Type II without increasing morbidity and 
mortality (Issel, 2009). Tertiary prevention decreases further complication of diabetes 
Type II through early intervention of cardiac care and skin care, such as heart disease and 
amputations (Issel, 2009). Knowledge of diabetes Type II obtained through scientific 
research including health education for clinicians and communities can help improve 
health outcomes. 
Problem Statement 
Diabetes Type II is a chronic disease that is prevalent in every community 
worldwide. According to Fonseca et al. (2012), nearly 26 million people in the United 
States have diabetes Type II. It was found that 25% of the population ages 25 and older 
have diabetes or are prediabetic (Fonseca et al., 2012). In the United States, 7.9 million 
people have prediabetes Type II, as opposed to 1 million people with diabetes Type I 
(Fonseca et al., 2012). Dall et al. (2010) found that the national cost for health care in 
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2007 was $218 billion. Furthermore, according to He, Black, Lopez-Payan, Omark, and 
Schillinger (2009), it cost California $24.5 billion to treat diabetics with Type II 
complications.  According to Gerber et al. (2010), a lack of adherence to diabetes Type II 
medications is high among Latino patients. There are many barriers that contribute to 
poor adherence not only to medications but to diet and exercise as well. These barriers 
relate to patients’ values and beliefs, socioeconomic status, a lack of support systems, a 
lack of knowledge of diabetes Type II, and transportation (Jin, Sklar, Oh, & Chuen, 
2008).   
Fortmann, Gallo, and Philis-Tsimikas (2011) conducted a multimediator cross-
sectional design model to show the importance of social support and community support 
resources. Fortmann et al. found that social support and community support resources had 
an effect on medication adherence among ethnic minority groups, including Latinos with 
diabetes Type II. The participants were mainly females with low socioeconomic status, 
below the federal poverty line, and low acculturation. Fortmann et al. asserted that the 
problems with Latinos adhering to medications diet and exercise still existed. 
Peek et al. (2007) concluded that ethnic groups, including Latinos with diabetes 
Type II, were at a higher risk of having complications related to chronic diseases. Ethnic 
minority groups have higher disparities in relation to diabetes Type II management 
outcomes and quality of life (CDC, 2011). Therefore, Healthy People 2020 encourage 
working at improving the quality of care and decreasing health care disparities among 
minority groups.  
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This study was needed to understand Latinos with diabetes Type II nonadherences 
to medications and their barriers relating to age, income, health education, migrant 
worker status, family size, and gender in order to improve their quality of life and prevent 
diabetes Type II complications. The World Health Organization (WHO, 2003) 
encouraged open communication between patients and providers to prevent 
misconceptions. Poor communication is one factor in increasing medication 
nonadherence. The health care team and health care system are related factors that are 
important when providing care to patients of other ethnicities such as African Americans, 
Asians, American Indians, and Latinos. Misconceptions are responsible for a lack of 
motivation from both the patient and provider. 
Purpose of the Study 
I used a retrospective quantitative method research design to develop an 
understanding of sociodemographic independent variables that may predict an association 
to medications adherence among Latinos with diabetes Type II. The independent 
variables included age, gender, income, migrant status, family size, and health education. 
The dependent variable was adherence to diabetes Type II medications. A logistic 
regression method was identified as the appropriate analysis criteria variable with two 
possible outcomes. The methodology involved a retrospective logistic regression, five 
independent variables, and one dependent variable. 
Research Question and Hypotheses 
The primary research question has six independent variables and one dependent 
variable.  This leads to six null and alternative hypotheses for testing. 
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RQ1: Are there predictors (age, gender, income, migrant worker status, and 
family size or health education) of nonadherence to medications among Latinos 
with diabetes Type II? 
H01: There is not an association between age and nonadherence to medications 
among Latinos with diabetes Type II. 
Ha1: There is an association between age and nonadherence to medications among 
Latinos with diabetes Type II. 
H02: There is not an association between gender and nonadherence to medications 
among Latinos with diabetes Type II. 
Ha2: There is an association between gender and nonadherence to medications 
among Latinos with diabetes Type II. 
H03: There is not an association between income and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha3: There is an association between income and nonadherence to medications 
among Latinos with diabetes Type II. 
H04: There is not an association between migrant workers and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha4: There is an association between migrant workers and nonadherence to 
medications among Latinos with diabetes Type II. 
H05: There is not an association between family size and nonadherence to 
medications among Latinos with diabetes Type II. 
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Ha5: There is an association between family size and nonadherence to 
medications among Latinos with diabetes Type II. 
H06: There is not an association between health education and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha6: There is an association between health education nonadherence to 
medications among Latinos with diabetes Type II. 
Multivariate Analysis  
A multivariate analysis method was used to test the association between 
medication nonadherence and adherence to determine if there were strong predictor 
values of any combination of two variables to diabetes Type II among Latinos. The 
independent variables were age, gender, income, health education, family size, and 
migrant worker status as predicators to medication nonadherence to determine an 
association among Latinos with diabetes Type II medication adherence. 
RQ2: Is there a combination of predictors to nonadherence to medications among 
Latinos with diabetes Type II? 
H07: The combination of age and gender is not a strong predictor of nonadherence 
to medications among Latinos with diabetes Type II. 
Ha7: The combination of age and gender is a strong predictor of nonadherence to 
medications among Latinos with diabetes Type II. 
H08: The combination of migrant workers and income is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
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Ha8: The combination of migrant workers and income is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
H09: The combination of age and health education is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha9: The combination of age and health education is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
H010: The combination of income and family size is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II.  
Ha10: The combination of income and family size is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
H011: The combination of gender and health education is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha11: The combination of gender and health education is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Theoretical Framework 
Two theories were used as the theoretical framework for the research study. The 
first was the social cognitive theory developed by Bandura (1998). The second theory of 
interest was the self-determinant theory (SDT; Skinner et al., 2003). Together these 
theories focus on the responsibility of care for oneself as it relates to diabetes. 
The Social Cognitive Theory 
The theoretical framework for the study was the social cognitive theory that 
includes the SDT (Bandura, 1998; Glanz, Rimer, & Lewis, 2002). Bandura (1998) 
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described the social cognitive theory as a multifactorial structure that operates in 
conjunction with goals, outcome opportunities, and assumed environmental social 
behavior. The theory facilitates actions that motivate humans’ health opportunities. 
Proponents of this theory emphasize three factors: environment, people, and how 
behavior affects a person’s actions and habits. Some concepts under the social cognitive 
theory include knowledge and skill, environmental perception, values placed on 
beneficial outcomes, the importance of self-monitoring, goal setting, and self-reward.  
This theory is a perception of patients’ abilities to enact behaviors, make lifestyle 
changes, and follow through on action plans. Self-efficacy is related to the cognitive 
social theory. This theory shifts the responsibility for care to the patient (Skinner, 
Cradock, Arundel, & Graham, 2003). The theory provides a framework for accepting and 
determining an association between the environment, social factors, and behavior. 
Understanding these behaviors and the personal social factors influencing these 
behaviors, whether environmental or culturally, can help in identifying social or 
environmental interventions influencing health outcomes (Bandura, 1998; Glanz et al., 
2002).  
Self-Determinant Theory 
The focus of the SDT is on control and motivation. This theory is similar to the 
social learning cognitive theory. However, the SDT requires more extrinsic actions by the 
individual. The SDT was part of the workshops used in the health district of Portsmouth, 
United Kingdom to assist individuals in understanding the Type II diabetes disease 
processes. Motivation is a highly known precursor for controlling diabetes Type II and 
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self-management (Skinner et al., 2003). In a study of 2,973 participants getting care from 
clinics using the integrated model from 2003 to 2004, Williams et al. (2009) used SDT as 
a way of orienting their participants to a better physical and psychological health. 
Developing a program that includes the SDT will allow the participants to be self-
efficient and self-motivated about adhering to the recommendation from their physician 
and other clinicians. SDT provides tools that assist patients in changing negative 
behaviors for positive lifestyle changes (Williams et al., 2009). 
Foundation for the Study 
Bandura (1998) theorized that lifestyle and behavioral changes by patients are not 
made at the spur of the moment, but by consciously developing methods of improving 
how they are going to behave and respond to the social environment. These methods are 
psychologically interpreted and self-directed and cause behavioral and lifestyle changes. 
The foundation for the theoretical framework used to guide the research was based on the 
concept that people cannot motivate themselves when attempting to change developed 
habits from a young age. Individuals with diabetes Type II can use the SDT (Skinner et 
al., 2003) and the social cognitive theory (Bandura, 1998) to self- monitor and self-
regulate their actions by learning the physical outcomes that motivate behavior. These 
include sensory experiences and physical social behaviors. In meta-analyses, researchers 
have verified the function of the SDT values, regardless of how diverse an individual 
might be in relation to health. Teaching the SDT and the social cognitive theory prepares 
the person to predict these base functions, including sociodemographics characteristics 
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and social factors relevant to chronic disease (Holden, Moncher, Schinke, & Barker, 
1990; Stajkovic & Luthans, 1998).  
Conceptual Framework 
Concepts in relation to diabetes Type II nonadherent behaviors and lifestyle 
changes are provided frequently in health care outpatient clinics, hospitals, and 
emergency rooms. There are many reasons for nonadherence and, even though education 
on nonadherance has been given for decades, the problem has not been resolved. Martin, 
Williams, Haskard, and DiMatteo (2005) discussed increased morbidity and mortality 
with nonadherence to medications affecting the patient’s well-being and increasing the 
health care economic burden relating to diabetes Type II complications. The concept of 
adherence management for Latino patients ought to be simple by eliminating complex 
recommendations, encouraging daily medication use, and incorporating lifestyle changes 
to diet and other behaviors. Martin et al. agreed that at least 40% of patients 
misunderstand instructions given for prescribed medication and forget or even disregard 
advice given by their physician or health educators. Twelve percent of people in the 
United States with diabetes Type II do not fill their prescription, 12% do not take their 
medication, 29% stop taking their medication before they run out, and 22% miss dosages 
in order to have their medication for a longer period of time (American Heart 
Association, 2009; Martin et al., 2005). Schectman, Nadkarni, and Voss (2002) noted that 
sociodemographics and low socioeconomic status also yielded poor diabetes Type II 
nonadherence, including negative health outcomes.  
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Peek et al. (2007) described diabetes Type II management classified by the target 
population, clinicians, and health care systems, concluding that patients have the ability 
to self-manage if properly educated, thereby improving their self-outcome. The limited 
number of epidemiological interventions that have been properly analyzed has 
contributed to the poor adherence among racial ethnic groups including Latinos (Elliot, 
Shinogle, Pelle, Bhosle, & Hughes, 2008). The models that have been tested had no 
target population or specific need in the health care system (Noble, Mathur, Dent, Meads, 
& Greenhalgh, 2011). The epidemiological prevalence of diabetes Type II is one in 10 
U.S. adults as reported in 2007 (Noble et al., 2011). The increase of diabetes Type II has 
affected individuals with limited resources, finances, education, and sociodemographic 
instability, adding to diabetes Type II complications, depression, and poor adherence to 
medications.  
The problems with medication nonadherence exist among several ethnic groups in 
the United States. However, nonadherence is more evident among people of limited 
resources, including Latinos. The conceptual framework was used to improve health care 
outcomes, prevent complications, and relate to the awareness of individuals’ necessities. 
These necessities include knowledge of the disease, sociodemographic surroundings, and 
motivation to self-manage the disease. The WHO (2003) noted that health education is 
not only for patients but clinicians as well to be able to deliver similar protocols where 
both the clinician and the patient are ready for adherence supported by a health delivery 
system. 
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Nature of the Study 
The intent of the study was to determine if there were predictors of nonadherence 
to diabetes Type II medications using a quantitative retrospective method design. The 
objective of this retrospective quantitative research study was to understand the 
association between the independent variables age, gender, income, migrant status, 
family size, and health education among Latinos with diabetes Type II.  
The logistic regression analysis was used to predict continuous variables, discrete, 
or a combination of continuous and discrete. Age was treated as a continuous variable, 
divided into age groups: 18 to 30 years of age, 31 to 45 years of age, 46 to 60 years of 
age, and 60 and over. Sex was classified as males versus females, health education as yes 
versus no, and migrant worker status as yes versus no. These were treated as dichotomous 
variables. Health education was determined by diabetes Type II health education classes 
the participant attended. Income was categorical dummy coded by the following 
classification 0= none, 1=$1 to $10, 000 per year, 2=$10,001 to $15,000 per year, 
3=$15,001 to 20,000 per year, and 4=$20,001 or more. The dependent variable in this 
analysis was adherence to medications; the two levels of variables were adherence versus 
nonadherence. A 95% confidence interval was used to represent the correlation between 
the independent variables and the dependent variable with a p value of less than 0.01, 
calculated by applying the Bonferroni correct. Overall model significance or the Omnibus 
test of model coefficients for the logistic regression was examined by the effect of the 
predictor variables on adherence to medication, presented with an X² coefficient. The 
Cox and Snell R² and Nagelkerke R² were used to examine the percentage of variance 
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accounted for the predicted variables. Predicted probabilities of an event occurring was 
determined by the expected (β; Tabachnick & Fidell, 2012).  
Logistic regressions overcome many of the restrictive assumptions of linear 
regressions. Linearity, normality, and equality of variance are not assumed, nor is a 
normally distributed error term variance assumed. The major assumption of the logistic 
regression is that the outcome variable must be discrete. The data should not contain 
outliers, and there should be a linear relationship between the odds ratio and the predictor 
variables (Tabachnick & Fidell, 2012). Linearity with an ordinal or interval predictor 
variable and the odds ratio can be checked by creating a new variable that divides the 
existing predictor variable into categories of equal intervals and running the same 
regression on these newly categorized versions as categorical variables. Linearity is 
demonstrated if the B coefficient increases or decreases the linear steps (Garson, 2009). 
Finally, a large sample is recommended, fitting with the maximum likelihood method. 
Using discrete variables requires that there are enough responses in each category.  
The data were collected using secondary, archived electronic medical records 
from a database at Clinica Sierra Vista in Fresno, California, a nonprofit primary care 
community clinic. This retrospective study covered the period from 2010 to 2014. The 
database at Clinica Sierra Vista was linked to i2i Media Tracks that serviced eight clinics 
from rural, suburban, and urban impoverished areas of Fresno, California. The data were 
entered into IBM SPSS Statistics Software (Version 21).  Frequencies, mean, and 
standard deviations were calculated for age, gender, income, health education, family 
size, and migrant worker status by adherence or nonadherence to diabetes Type II 
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medications. Depending on the predictors, an outcome action plan with recommendations 
to patient management and adherence to diabetes Type II medications was prepared. The 
results of the data were presented to both clinicians and staff for them to encourage 
patients to enter medication assistant programs, health system resources, and free 
medication pharmaceutical programs available to patients with limited income. 
Definitions 
Adherence: The extent that patients take their medications, exercise and follow a 
strict diet as directed by a clinician or medical physician (Skinner et al., 2003). Diabetes 
Type II medication nonadherence is related to age and gender. Fischer et al. (2010) 
described age and gender as possible predictors. However, the literature was limited in 
the number of patients who fail to fill their prescriptions as recommended by their 
physician and recommendations to exercise and diet. Fischer et al. described males and 
younger adults as having better adherence to medications as prescribed by physicians. 
Latinos, both males and females, have a higher rate of nonadherence to medications with 
a higher number of complications (Peek et al., 2007).  
 Diabetes Type II: An illness that interrupts the body glucose pathway. Every cell 
in the body needs glucose in order to function to its optimal potential. The glucose gets 
into the cell with the help of an insulin hormone. When insulin is depleted, or the body 
stops releasing insulin, glucose increases in the blood stream (McCulloch, Nathan, & 
Mulder, 2012). 
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Nonadherence: This term relates to a prescription or recommendation from a 
clinician not followed by a patient. Nonadherence to medication is multifactorial and 
changes with each situation and patient (White, 2011).  
Primary prevention: Actions, activities, or interventions done to prevent disease 
or illness. An example is daily exercise, a diet lower in cholesterol, salt, and fat, and 
maintaining appropriate calories as recommended by the CDC, health educator, 
nutritionist, or physician (Issel, 2009).  
Secondary prevention: Providing screening tools for prediabetes or for diabetes 
type II to start early intervention (Issel, 2009).  
Tertiary prevention: Interventions or actions to prevent further complication of 
diabetes Type II. Tertiary prevention assists in preventing diabetes Type II complications 
such as amputations or renal disease (Issel, 2009). 
Assumptions 
Perez-Escamilla, Garcia, and Song (2010) described acculturation as playing a 
role in migrant workers’ abilities to access health care. Increased risk behaviors such as 
drug abuse, unsafe sex practices, chronic as well as infectious diseases, and nonadherence 
to medications are behaviors affecting the Latino migrant workers. Perez-Escamilla et al. 
noted that migrant workers and Latinos born in the United States with family ties in 
Mexico often received health care from Mexico, including purchasing medications from 
Mexico through a relative or friend. The migrant worker population is usually not well 
documented, and specifics of the numbers are difficult to assume. Moreover, the migrant 
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worker population is unknown, moving from one state to another with their families, 
looking for agricultural work.  
There are many cultural beliefs within the Latino population that determines the 
outcome of diabetes Type II, such as El Susto. El Susto is a form of fear caused by 
someone or something in the environment precipitating the beginning of an illness such 
as diabetes Type II (Swan, 2010). Fatalismo is another health belief that determines the 
individual’s response to diabetes Type II. Fatalismo means that the person cannot change 
the direction of the disease (Campos, 2007). Familismo is an important aspect of the 
family. The need of the family and other families come first, similar to the compadre 
belief. Rios (1998) described Espiritismo as the belief system made of both good and evil 
spirits that can affect a human’s health and quality of life.  
Many Latinos depend on curanderos, a folk healer who uses home remedies and 
herbs. The Latino population believes that curanderos have mental powers and abilities to 
cleanse the body from evil spirits, including skills to manage many acute diseases as well 
as chronic illnesses. Patients keep this information to themselves in fear of being judged 
by Western medicine clinicians. Sociodemographics are variables that determine the 
course, interest, and self- management of diabetes Type II by patients. The beliefs above 
increase the assumption that the health history is not always accurately reported or 
completed.  
The study depended on the assumption that the archive electronic medical records 
in the database were accurate and entered using precise data information by the 
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originators of the data. It was assumed that the information provided by the patients was 
accurate, including risk factors to diabetes Type II. 
Scope 
The retrospective quantitative research method design was done using a 
secondary archived medical record review. This quantitative retrospective research study 
covered the period from 2010 to 2014. The target population was Latinos from Fresno, 
California age 18 and over with diabetes Type II. 
Delimitation 
The data were collected using secondary electronic archived medical record 
reviews. The participants were mainly Latinos with diabetes Type II, males and females, 
age 18 and over. Clinica Sierra Vista serviced eight clinics from rural, suburban, and 
urban impoverished areas of Fresno. Nonadherence to diabetes Type II medications 
among Latinos is a problem, increasing the complication rate and cost to the nation. The 
study was limited to the sociodemographic variables of age, gender, income, migrant 
worker status, family size, and health education. However, there are many variables 
related to diet, physical activity, depression, folk remedies, and acculturation that 
required further studies addressing the needs of Latinos with diabetes Type II. 
Limitations 
A disadvantage of a retrospective cohort study relates to the limited information 
with no avenue for follow-up, providing only prior outcomes. Another limitation of a 
retrospective design study is that it cannot identify cause and effect. Retrospective 
research studies are prone to selection bias, secondary to loss of records. Due to limited 
21 
 
 
access to data, the target population was limited to Latinos with diabetes Type II located 
in Fresno, California. Latinos are Mexican Americans, immigrants from Mexico, Central 
America, South America, and any other Hispanic person including Portuguese. New 
patients diagnosed with diabetes Type II in 2014 may have limited information on 
medication nonadherence. 
Data were collected up to 5 years back in order to have an increased sample size. 
The possible responses to the predictors defined were limited for consistency. Hypothesis 
testing and statistical testing were done to prevent systemic errors. 
The data were dependent on patients who had identified themselves as being of 
Latino race on their data sheets. Some patients, however, might have falsely identified 
themselves as being Latino, while patients who are Latino might not have identified 
themselves as being of Latino race. 
Significance of the Study 
Horton (2012) described diabetes Type II complications as having a high impact 
on their quality of life. This quality of life is impacted by diabetes Type II complications, 
medication nonadherence, depression, no access to care, and hospitalizations. Horton 
recommended understanding patients’ characteristics, their view of health care, and their 
understanding of the disease. The health care provider’s approach to patients will 
determine an effective positive outcome; including the patient’s social environment and 
cultural barriers (Horton, 2012). Nonadherence to medications impacts the patients’ well 
being, including their quality of life. Understanding why Latinos, one of the largest 
groups in the United States, lack adherence to medications is an important step in 
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improving health care outcomes for this population. Health care costs will be decreased 
due to reduced complications, improved quality of life, and reducing morbidity and 
mortality among Latinos with diabetes Type II. 
Summary 
Chapter 1 contained an introduction to diabetes Type II medication nonadherence 
among Latinos in the United States, the implications of diabetes Type II nonadherence to 
medications, and how it relates to the sociodemographics predictors among Latinos, 
including migrant workers. In this chapter, I provided information relating to prediabetes 
and diabetes Type II complications and costs to the state, nation, community, and 
individuals. Diabetes affects young individuals’ health including obesity, hypertension, 
hyperlipidemia, and depression. I discussed the associations between the variables and 
the outcome of diabetes Type II. The emphasis was on the Latino community in Fresno, 
CA. This target population is at a higher risk of developing diabetes Type II at a young 
age. Chapter 2 is a detailed description of the theoretical framework and literature 
reviewed. Chapter 3 provides the methodology for the study. In Chapter 4, I present the 
results of the study. In Chapter 5, I describe recommendations for future study and study 
implications. 
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Chapter 2: Literature Review 
Introduction 
 Diabetes Type II is a chronic disease prevalent in every community worldwide. 
According to Fonseca et al. (2012), nearly 26 million people in the United States have 
diabetes Type II.  Twenty-five percent of the population ages 25 and older have diabetes 
or are prediabetic (Fonseca et al., 2012). Gerber et al. (2010) found that nonadherence to 
diabetes Type II medications, which is the cause for many diabetes Type II 
complications, is high among Latino patients. The National Diabetes Education Program 
(2007) reported that cardiovascular disease is a problem for persons with diabetes Type 
II, leading to disability and early death. The National Diabetes Education Program added 
that 65% of individuals with diabetes Type II die from coronary artery disease and stroke 
(Fonseca et al., 2012).    
 There is a 60% nonadherence to medications among Latinos with diabetes Type II 
(Parada, Horton, Cherrington, Ibarra, & Ayala, 2012). Thus improving adherence to 
diabetes Type II medications is a goal for every health care provider. However, 
nonadherence to medications, diet, and exercise is a problem that carries many 
complications; it affects the individual’s self-concept and self-satisfaction (Delamater, 
2006; Gerber et al. 2010). Salas, Hughes, Zuluaga, Vardeva, and Lebmeier (2009) argued 
that nonadherence to medications affects the cost effectiveness of pharmaceuticals, 
costing the U.S. economy close to $100 billion per year. Lau and Nau (2004) researched 
oral antihyperglycemic medication nonadherence preceding hospitalization and found 
that 28.9% of diabetes Type II participants were nonadherent to medications. Researchers 
24 
 
 
have described the significance of research with strategies to help patients understand the 
importance of taking their medications.  
 Chapter 2 is divided into six sections. Each section provides information 
regarding different topics. These sections are as follows: The introduction contains a brief 
overview and statistical figures related to other studies; the literature search strategy 
includes terms and criteria; the theoretical foundation and the conceptual framework 
include the theories used in different studies; an extensive review of the literature relates 
key variables and concepts to sociodemographic predictors of medication nonadherence; 
and the final section includes a summary and conclusion. 
Literature Search Strategy 
 The literature review was conducted using peer-reviewed articles dating from 
1992 to 2012 on diabetes Type II medication nonadherence, adherence, and the 
theoretical framework. The resources used included EMBASE, Cochrane Library, 
Walden University Library, PubMed, Medline, and the National Library of Medicine. 
Key terms used included nonadherence, adherence, compliance, cost, resource 
utilization, and medication expenses. Other key terms are diabetes Type II, 
hyperglycemia, antidiabetic medications, insulin, oral anti diabetic agents, and diabetes-
related complications.    
Criteria selection for the peer-reviewed studies depended on publication date, 
giving priority to articles from 2005 to present. Studies that related to glycosylated 
hemoglobin (hbA1C) as a proxy were used as an alternative to medication adherence.  
hbA1C is a well-accepted measurement of diabetes Type II hyperglycemic controls. 
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Studies were excluded if the article provided insufficient data or did not have adherence 
information. 
Nonadherence is defined by different methods. Delamater (2006) defined 
nonadherence as not following recommendations from physicians, dietitians, or 
counselors. These recommendations relate to medications, diet, or exercise. Leichter 
(2005) described nonadherence, as opposed to noncompliance, determining that the two 
terms are similar. Noncompliance denotes a negative opinion in relation to diabetes, 
whereas nonadherence implies failure to follow prescriptions given to patients by 
physicians or counselors without partiality. Parada et al. (2012) studied Spanish-Speaking 
Mexican-origin adults living along the US-Mexican border and found that 65% were 
classified as nonadherent to medications and did not follow diabetes Type II 
recommendations relating to behavior and lifestyle changes. 
Theoretical Foundation 
The theoretical foundation includes the theories used in different studies and the 
relation to the theoretical framework. There have been different theories applied in past 
research studies regarding nonadherence as opposed to adherence to medications, diet, 
and exercise. White (2010) compared two groups of patients in Denmark. One group was 
continually evaluated by their physicians using diabetes Type II specific-goals, 
information, patient education, patient feedback about the management of diabetes Type 
II, and an assessment of the outcomes. The second group was set up using a conventional 
approach with nonintervention physicians. The group with goal settings responded with 
positive outcomes, decreased hbA1C, decreased blood glucose, lower blood pressure, and 
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decreased cholesterol levels at the end of 6 years. The conventional therapy group of 
diabetes Type II participants had negative outcomes with no changes in their lifestyle 
behaviors (White, 2010). Another method of changing lifestyle behaviors in patients with 
diabetes Type II was the use of systems interventions. This type of intervention attempts 
to improve environmental factors that guide self-management by intervening with 
economic determinants. The intervention is done through policies and protocols to 
provide for test strips, lancets, and glucose meters. Other programs, such as 
transportation, are also provided to improve the quality of care (White, 2010). In order to 
improve patient adherence, patients and physicians must take an active role in health 
education relating to medications, diet, and exercise. Adherence to diabetes Type II 
medications requires theories and philosophies related to self-management and education 
of individuals with diabetes Type II. Skinner et al. (2003) described the self-regulation 
theory that focuses on individuals’ behaviors, emotions, and response to the disease. The 
six core basic elements are  
1.  Identify signs and symptoms of the disease.  
2.  Describe the risk factors relating to diabetes Type II. 
3.  Be aware of how long a person has diabetes Type II.  
4.  Understand the consequences of diabetes Type II in the present and in the    
future.  
5.  Explain how to maintain diabetes Type II daily controlled.  
6.  Know the complications of not treating diabetes Type II.  
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Dual Process Theory  
The dual process theory has been used in the education of diabetes Type II disease 
processes. The health district of Portsmouth, United Kingdom conducted a series of self-
management workshops for patients newly diagnosed with diabetes Type II to improve 
adherence to medications, diet, and exercise. The individuals were asked about their 
understanding of diabetes Type II as well as the signs and symptoms. These individuals 
were provided with information regarding diabetes Type II (Skinner et al., 2003). Skinner 
et al. (2003) used the theory to improve diabetic education in assisting individuals with 
diabetes Type II to follow medication, diet, and exercise recommendations. Through 
active participation, the individuals with diabetes Type II were able to understand the 
meaning of diabetes, the management of the disease, and the prevention of complications. 
The individual was responsible for active participation in their lifestyle behavioral 
changes and self-management. This included improving adherence to medication, diet, 
and exercise (Skinner et al., 2003). 
Self-Determinant Theory  
The focus of the SDT is on control and motivation. This theory is similar to the 
social learning cognitive theory. The exception is that it requires extrinsic actions by the 
individual. SDT was part of the workshops used in the health district of Portsmouth, 
United Kingdom to assist individuals in understanding the diabetes Type II disease 
processes. Motivation is a precursor for controlling diabetes Type II and self-
management (Skinner et al., 2003). In a study of 2,973 participants getting care from 
clinics using the integrated model from 2003 to 2004, Williams et al. (2009) used SDT as 
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a way of orienting their participants to better their physical and psychological health. 
Williams et al. concluded that developing a program that included the self-determinant 
theory will allow the participants to be self-efficient and self-motivated about adhering to 
the recommendation from their physician and other clinicians. The SDT provides tools 
that assist patients in changing negative behaviors for positive lifestyle changes 
(Williams et al., 2009).  
Social Cognitive Theory  
The social cognitive theory is the perception of patients’ ability to enact 
behaviors, make life style changes, and follow through on action plans. SDT is related to 
the cognitive social therapy. This theory shifts the responsibility for care to the patient 
(Skinner et al., 2003) and was used as the theoretical framework of the research study; it 
includes the self-efficacy learning theory (Bandura, 1998; Glanz et al., 2002). Bandura 
(1998) described the theory as a perceived multifactorial structure that operates in 
conjunction with goals, outcome opportunities, and assumed environmental social 
behavior; facilitating actions that motivate humans in health opportunities. This theory 
includes three factors: environmental, people, and how behavior affects a person’s 
actions and habits. Some concepts under the social cognitive theory include knowledge 
and skill, environmental perception, values on beneficial outcomes, the importance of 
self-monitoring, goal setting, and self-reward. The social cognitive theory provides a 
framework for accepting and determining an association between the environment, social 
factors, and behavior. Understanding these behaviors and the personal social factors 
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influencing these behaviors can help in identifying social or environmental interventions 
influencing the outcome (Bandura, 1998; Glanz et al., 2002).  
Bandura (1998) theorized that that lifestyle and behavioral changes are 
consciously developed methods of improving how patients are going to behave and 
respond to the social environment. These functions are psychologically interpreted and 
self-directed to be able to cause behavioral and lifestyle changes. The foundation for the 
theoretical framework that was used to guide the research was based on the concept that 
people cannot motivate themselves when attempting to change learned habits from a 
young age. Therefore, the SDT and social cognitive theory empower individuals with 
diabetes Type II to self-monitor and self-regulate their actions by learning the physical 
outcomes that motivated behavior. These physical behaviors include sensory experiences 
and physical social pleasures. The risk factors that influence diabetes Type II are a part of 
the cycle. In meta-analysis studies, researchers have verified the function of self-efficacy 
values, regardless of how diverse an individual might be in relation to health. The SDT 
and social cognitive theory prepare the person to predict these base functions including 
sociodemographics characteristics and social factors relevant to chronic disease (Holden 
et al.,1990; Stajkovic & Luthans, 1998). 
Conceptual Framework 
Concepts in relation to diabetes Type II nonadherent behaviors and lifestyle 
changes are heard frequently in health care outpatient clinics, hospitals, and emergency 
rooms. There are many reasons for nonadherence, and even though education programs 
have been given for decades, the problem has not been resolved. Martin et al. (2005) 
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discussed increased morbidity and mortality with nonadherence to medications affecting 
the patient’s wellbeing and increasing the health care economic burden relating to 
diabetes Type II complications. The concept of adherence management for Latino 
patients ought to be simple, eliminating complex recommendations, encouraging daily 
medication use, lifestyle changes to diet, and other behaviors such as exercise. Martin et 
al. agreed that at least 40% of patients misunderstand instructions given for prescribed 
medication and forget or disregard advice given by their physician or health educators. 
Twelve percent of Americans with diabetes Type II do not fill their prescription, 12% do 
not take their medication, and 29% stop taking their medication before they run out, and 
22% take their medication to have medication for a longer period of time (American 
Heart Association, 2009; Martin et al., 2005). Schectman et al. (2002) noted that 
sociodemographics and low socioeconomic status also yielded poor diabetes Type II 
nonadherence, including negative health outcome. 
Theorist and Philosophers 
Gorge (1994) stated that a vegan diet should not be promoted as a way of life 
because the financial limits of such a diet make it possible only for those with financial 
means; others could not consume it safely. However, Tonstad, Butler, Yan, and Fraser 
(2009) found in a study of 22,434 men and 38,469 women that vegetarianism potentially 
protects against obesity and diabetes Type II. Many vegan individuals see this diet as a 
phenomenon that helps decrease not only obesity but elevated lipids as well decreasing 
cardiac events, which prevents early onset of diabetes Type II (Tonstad et al., 2009).  
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The philosophy of Kaira et al. (2010) was based on patient advocacy and placing 
the individual at the center rather than diabetes Type II. The goal of Kaira et al. was to 
educate and empower individuals with diabetes Type II to adhere to diet, medications, 
physical activities, and other recommendations to better the quality of life and outcome. 
Snyder (2012) claimed that diet and exercise are first and medications second. This 
philosophy’s concept is on diet control and weight loss. Snyder determined that if an 
individual with diabetes loses at least 7% of weight, this individual has a better chance of 
controlled diabetes Type II. Skinner et al. (2003) also placed the responsibility on the 
patient. The patient is responsible for making decisions that will assist in being in control 
of his or her diabetes Type II physical and emotional health outcomes. Snyder’s 
recommendations were not only for the patient but for the health care provider as well to 
treat the patient with respect, empathy, and warmth and to make the educational 
experience a success. The philosophy of treating others with respect is valuable, 
especially when working with people from different educational, cultural, and ethnic 
backgrounds. 
Stajkovic and Luthans (1998) examined self-efficacy, work-related performance, 
and a correlation between self-efficacy and performance. Stajkovic and Luthans, used the 
social cognitive theory, both self-reactive and contextual characteristics that influence 
how the person views or perceives behavior. They also examined the association between 
individuals and the overall basis for their behaviors, determining that there is a 
correlation between self-efficacy and work-related behaviors. These work-related 
behaviors include social behaviors as well as work-related health determinants such as 
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depression, anxiety, and a lack of motivation. The social behaviors are related to 
overeating, substance abuse, and smoking. 
Literature Review Related to Key Variables and Concepts 
Physiological Theories  
The endocrine cells of the pancreas are located in the islets of Langerhans, made 
up of two types of cells, Alpha-cells and Beta-cells. These cells are found scattered all 
around the islet of Langerhans. The Beta cells make up 60% of the endocrine body of the 
pancreas, responsible for insulin and myelin. Insulin is released in response to glucose 
levels (Spellman, 2010).   
DeFronzo and Tripathy (2009) concluded that skeletal muscle is the major site of 
glucose uptake in humans in the postprandial state. DeFronzo and Tripathy noted the 
changes in leg muscle through the precise estimate of leg muscle glucose uptake with 
positron emission tomography, a tool proven effective in providing new information 
about reduced muscle insulin tissue resistance in diabetes Type II. Glucose is not used by 
the muscle cells with diabetes Type II. However, glucose is released into the blood 
stream causing a hyperglycemic state. This change in insulin resistance increases 
metabolic abnormalities, (DeFromzo & Tripathy, 2009; Spellman, 2010). 
In a person with diabetes Type II, it is important to understand the action of 
carbohydrates and insulin. After eating a meal, carbohydrates are broken down into small 
glucose molecules in the gut. These glucose molecules are absorbed into the blood stream 
elevating the glucose levels. The elevated glucose stimulates release of insulin from the 
beta cells in the pancreas. Insulin allows the entrance of glucose into most of the cells to 
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be used as energy by binding to certain cellular receptors (Leahy & Pratley, 2011). When 
glucose levels exceed the cell needs, the extra glucose is stored in the liver as glycogen. 
The liver acts as a reservoir until glucose is needed by the cells. The liver produces 
glucose from fatty acids and from proteins or amino acids through a process of 
gluconeogenesis. Glycogenolysis and gluconeogenesis together help in increasing blood 
glucose levels. Glycemia is controlled by a complex relation between the stomach, 
pancreas, and the liver (Mealey, 2005). 
Glycogenolysis  
Glycogenolysis is how the body breaks down glycologen into glucose from the 
liver and muscle tissue before it is used by the body. The breakdown can be of muscle 
tissue called glucose 6-phosphate. The breakdown occurs in the cytoplasm of cells; 
glycogen is the main product from carbohydrates. Glycogenolysis occurs during periods 
of fasting or during exercise to provide 6-phosphatate for glycolysis as needed for 
Adenosine Triphosphate (ATP) (Cellular Respiration, 2012). 
Gluconeogenesis  
Gluconeogenesis is the process of glucose from noncarbohydrate foods. The 
major originators are pyruvate, lactate, glycerol, and glucogenic amino acids. A few main 
organs require a constant supply of glucose to be used as energy. These organs are the 
brain, renal medulla, erythrocytes, lens and cornea of the eye, exercising muscles, and 
testes. About 90% of gluconeogenesis occurs on the liver and about 10% of 
gluconeogenesis occurs in the kidney (Cellular Respiration, 2012) 
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There are many other theories relating to diabetes Type II function and 
dysfunction, as well as theories on how to approach this chronic disease. Leahy and 
Pratley (2011) theorized that adipose tissue leads to insulin resistance and diabetes Type 
II. This theory is known as the lipotoxocity ectopic theory. The lipotoxocity ectopic 
theory alters the redistribution of fat in the skeletal muscle, liver, and beta cells by 
sending messages to adipose tissue molecules increasing an adipose tissue inflammatory 
response. This inflammatory response is known as the secreted factor theory that causes a 
low grade pro-inflammatory response affecting the insulin production and beta cells 
function leading to diabetes Type II (Leahy & Pratley, 2011). Leahy and Pratley pointed 
to central obesity or the fat found around the waist. This fat is not considered to be 
subcutaneous fat predisposing people to insulin resistance and diabetes Type II. 
Lebovitz ‘s (1999) theory was that diabetes Type II depended on genetic, as well 
as environmental factors, and that it resulted from evolution of a thrifty genotype that had 
survived in the past but has grown in the present time. Lebovitz compared the theory and 
determined that it represents an adult metabolic response to fetal malnutrition. Lebovitz’s 
philosophy was that diabetes Type II is attributed to insulin deficiency. Lebovitz’s theory 
has been controversial. However, Khoury, Bedrosian, Gwinn, Ioannidis, and Little (2010) 
identified phenotype similarities among families with diabetes Type II. 
Remington, Brownson, and Wegner (2010) noted that there are many factors that 
contribute to diabetes Type II such as smoking, obesity, hypertension, and elevated lipids. 
Other contributing factors consist of physical inactivity, poor diet, smoking, and alcohol 
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consumption. Obesity increases the risk of insulin resistance, increasing a chance for 
diabetes Type II (Remington et al. 2010). 
Rubino’s (2008) theory is that the problem with diabetes relates to the duodenum 
or the small bowel in the pathophysiology of the disease. Rubino discussed the 
rearrangement of the gastrointestinal anatomy as a primary means of preventing or 
stopping diabetes Type II in morbid obese individuals. Rubino theorized that diabetes 
Type II is an intestinal disease, proposing Roux-en-y gastric bypass surgery, in 
combination with bilious-pancreatic diversion (BPD). 
 Pathogenesis of Diabetes Type II 
Diabetes Type II is not clearly understood. It is believed to be linked to obesity 
and genetic predisposition to certain families within the same culture. Diabetes Type II is 
also recognized in groups with low socioeconomic position (Ramlo-Halsted & Edelman, 
2000). Diabetes Type II is higher in Latinos, African Americans, Pacific Islanders, and 
American Indians.  Ramlo-Halsted & Edelman determined that many risk factors 
contribute to diabetes Type II insulin resistances such as obesity, aging, and a lack of 
exercise. They also concluded that a lack of self- management comprehension and 
decreased cognitive abilities contribute to risk factors that increase the complications of 
diabetes Type II, including elevated glucose and free levels of fatty acids. 
Diabetes Type II is considered to be a metabolic triad defect affected by insulin 
resistance, B-cell dysfunction, and hepatic glucose dysfunction (Ramlo-Halsted & 
Edelman, 2000). Insulin resistance is recognized by high levels of glucose in the blood 
stream. Pancreatic B-cell dysfunction is caused by the release of increased levels of 
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glucose stimulating insulin. Impaired hepatic dysfunction is caused by increased glucose 
production. After eating, persons with diabetes Type II have a combination of increased 
glucose postprandial, ineffective release of insulin, and suppression of glucose output 
needed by target tissue cells, such as skeletal muscles (Ramlo-Halsted & Edelman, 2000). 
Obesity, a lack of exercise, and risky behaviors such as smoking and alcohol 
consumption contribute to increased glucose and decreased insulin from the pancreas B-
cells. In time, insulin resistance becomes chronic where no insulin is released and 
exogenous insulin is required (Ramlo-Halsted & Edelman, 2000). Many patients have no 
concept of why they have diabetes Type II. Latinos believe that it is part of el susto, a 
frightening experience that causes an acute stress situation affecting the body physically 
and mentally. 
Diagnosis of Diabetes Type II 
The American Diabetes Association’s (2012) new recommendations differ from 
the old recommendations. The old recommendations for diabetes Type II were based on 
fasting plasma glucose (FPG) or a two hour value after taking 75 gram of oral glucose 
tolerance test (OGTT). The new recommendations were standardized by the American 
Diabetes Association, the International Diabetes Foundation (IDF), and the European 
Association for the Study of Diabetes (EASA). The EASA made recommendations to use 
the hbA1C test as a mean of diagnosing diabetes Type II, with a threshold of >6.5%. 
Their recommendations were accepted by the American Diabetes Association in 2010 
(American Diabetes Association, 2012).  
37 
 
 
Epidemiology 
Inzucchi et al. (2012) noted that diabetes Type II prevalence is increasing 
worldwide, but at a higher number in underdeveloped countries and higher among 
individuals with obesity, elevated hyperlipidemia, and hypertension. The trend is thought 
to be related to lifestyle behaviors that are associated with the Western world, in 
particular, diet and exercise. The economic burden is high and continues to climb 
(Inzucchi, 2012). Chan (2010) reported that 10% of hospitalizations and 23% of nursing 
home admissions per year are related to diabetes Type II non adherence, increasing the 
health care cost to around $100 billion a year. Parada et al. (2012) documented an 
increase in medication nonadherence of Latinos with diabetes Type II. The study was a 
randomized controlled trial of 302 patients randomly sampled, and Parada et al. found 
that 60% of patients were nonadherent to diabetes Type II medications. Latinos are more 
likely to have a higher rate of nonadherence to diabetes Type II medications (Horton et 
al., 2012). Nonadherence to medications, diet, and exercise remains the most important 
reason for cardiovascular disorders, blindness, end-stage renal failure, amputations, and 
hospitalizations (Martin et al., 2005).  
Kockaya and Wertheimer (2011) revealed that diabetes Type II is linked to 
depression, decreased cognitive abilities, cancer, neuropathies, and other disabling 
conditions, including death. In a study done between 1998 and 2002, the CDC (2011) 
found that where Latinos dwell is of importance on how diabetes impacts each person’s 
life due to cultural influence. Wabe, Angamo, and Hussein (2011) indicated that the 
worldwide adherence rate of diabetes Type II medications was approximately 36% to 
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93%, depending on the demographics and socioeconomic status of the individuals. Wabe 
et al. found that prescriptions in Ethiopia were given to 351 patients. Out of the 351 
patients, 33 were prescribed insulin and 312 were prescribed oral hypoglycemic 
medications. Out of the patients receiving oral medications, only 42.8% of patients 
showed proper glycemic control. The reasons for nonadherence to medications as 
reported to the investigators were limited finances and the fear of side effects from drugs. 
A study done in the Netherlands showed that adherence to oral medications was 
approximately 61% to 85% (Vervloet et al. 2011).  In Nigeria, Adejoh (2012) showed 
that 66% of patients were nonadherent to oral diabetes Type II medications. Chan (2010) 
found that in the United States, adherence to medications was approximately 36% to 93% 
depending on demographics and socioeconomic factors. Miccoli, Penno, and Del Prato 
(2011) found in a retrospective cohort study of 2,741 participants, using the patient’s 
medical and pharmacy claims from a managed care plan in Oregon, that nonadherence to 
medications was 19% to 35%.  In studies done of Latinos and Nigerians compared to the 
Netherlands and Oregon researchers showed that patients of low socioeconomic factors 
and demographics had a higher rate of diabetes Type II medication nonadherence.   
Literature Review Related to the Study 
 The intent of the research study was to determine predictors of nonadherence to 
diabetes Type II medications using a quantitative method design. The objective of this 
retrospective quantitative research study was to develop an understanding of  the 
sociodemographic independent variables, age, gender, income, migrant worker status, 
family size, and health education to predict adherence to medications among Latinos with 
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diabetes Type II. A binary logistic regression with multiple variables was conducted. The 
dependent variable was adherence to medications. The logistic regression permitted the 
evaluation of the odds of membership in adherence versus nonadherence, overcoming 
many of the restrictive assumptions of linear regression. 
Methodology Relating to the Research Study 
Gerber et al. (2010) discussed a mixed method study of nine patients with a mean 
age of 58 years who had diabetes for 21 years or more. The clinical staff at the University 
of Illinois, Chicago Medical Center assisted Latino patients with poorly controlled 
diabetes Type II, determined by a hbA1C > 8.0%.  A team research member assisted the 
patients by completing their history, medication list, health literacy, medication benefits, 
depression, social support and access to care, diabetes knowledge, language spoken in the 
home, and numeracy. The team promoter of health worked with these patients at home, at 
a clinic, and through telephone calls. Medication management was provided for 6 
months. The health promoters worked to maintained open communication between the 
pharmacist and the patient and in preventive complex patient barriers. The team worked 
at improving medication adherence and to teach self-care adherence among Latinos with 
Type II diabetes. The study required many hours of frequent communication with 
patients, means to address barriers, and telephone call time to discuss any issues with 
participants. The study was based on their hbA1C, health education, knowledge of 
diabetes, and language spoken in the home. Their sociodemographics were used to aid in 
improving the blood glucose levels for Latino patients with hbA1C > 8.0% residing in 
low socioeconomic areas. The study provided information on the importance of 
40 
 
 
collaboration with other health care providers such as the pharmacists, counselors, health 
educators, and other members of health care teams. 
The WHO (2003), in a review of literature using a cross-sectional design, found 
that medication adherence is related to socioeconomic status depending on the diabetes 
medication regimen. Fifty-nine patients, 25 years and older, were followed regarding 
medication adherence. The WHO found that poor communication between patient and 
provider increases the rate of nonadherence to medications. Therefore, health care teams 
and health systems are important when providing care to patients of other ethnicities such 
as African Americans, Asians, American Indian, and Latinos. Strategies and goals ought 
to be set up first by the health care teams in order to improve communication to prevent 
misconceptions (WHO, 2003). These misconceptions are responsible for a lack of 
motivation from both the patient and the provider.  
Studies have lacked adherence standards as part of the intervention or motivation 
process. Miscommunication between the patient and provider created a deficit in the 
patient’s health education with no intervention on how to reach the patient. The WHO 
(2003) reviewed literature published from 1980-2001 and found that research on 
adherence to diabetes Type II medications yields inconsistencies including variability. 
More research is needed using instruments and different research designs. Variables 
relating to general measurements such as gender, age, and complexity of treatment are 
needed as opposed to specific variables (WHO, 2003). The sample size to meet the 
research design is important for validity of the study to detect significant correlations 
between the different variables. 
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The variables used by the research studies included health status, behavioral 
observations, permanent products, patient self-reports, diaries, and 24 hour recall 
interviews. These indicators are important in the care of patients with diabetes Type II. 
The problem with some of indicators is that they attract bias (WHO, 2003). Researchers 
have shown factors that influence behaviors of diabetes Type II. The WHO (2003) 
discussed the intrapersonal factors that affect behavior such as age, gender, self-esteem, 
self-efficacy, stress, depression, and alcohol abuse. The interpersonal factors are 
important to the well-being of patients. These factors are the quality of communication 
between the patient, the provider and the patient’s social support system. The patient 
must have some understanding of diabetes Type II, motivating them to adhere to the 
provider’s recommendations and treatment regimen. The WHO discussed the 
environmental factors, including the high risk situations and environmental systems. 
Mann et al. (2009) researched diabetes Type II using a multivariate analysis 
research design to predict association of medication nonadherence. Using a quantitative 
method, Mann et al. used 151 participants from the inner city, measuring 
sociodemographics factors, age, gender, employment, language, ethnicity, and income.  
Mann et al. added to the variables hbA1C, diabetes history, and comorbidity as reported 
by the patient. The study used the self-efficacy or regulation theory to base their research. 
The study was made mainly of African American and Latinos residing in low 
socioeconomic areas. Sixty-four percent of the participants were born in the United 
States, and 31% were born in Puerto Rico. The participants reported high levels of 
comorbidity. The comorbid condition included 80% who had hypertension and 61% of 
42 
 
 
the participants who had hyperlipidemia. Other comorbid conditions affecting the 
participants included 43% with depression and 23% with anxiety (Mann et al. 2009). The 
univariate predictors of medication non adherence were around 28%. These individuals 
had five beliefs about their diabetes Type II.  
1. You only have diabetes when your sugar is high. 
2. There are no consequences for poor nonadherence to diabetes Type II 
medications. 
3. Diabetes has no symptoms. 
4. They have no control of their diabetes Type II. 
5. Diabetes interferes with their regular life. 
The patients were divided into four medication beliefs: skeptical 6%, ambivalent 34%, 
indifferent 5%, and accepting 55%. The skeptical participants were more likely to be 
nonadherent. The ambivalent participants had a p=0.02, the participants who were 
indifferent had a p= 0.03, and the participants who were accepting had a p= 0.001 (Mann 
et al., 2009).  Numerous studies have been done on nonadherence. However, 
nonadherence problems continued to exist. The study emphasis was on the inner city 
population. Using self-reporting for medication adherence and the sample size prevented 
accurate associations between the variables. The health education from the participant’s 
point of view was not given in a way they could understand or comprehend what was 
being taught. The sociodemographic was inconsistent due to variation in study design and 
target population (Mann et al., 2009). 
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Mann et al. (2009) found that patients’ beliefs were inconsistent in relation to the 
chronic disease model of diabetes Type II. Patients residing in the inner city had health 
beliefs predictive of medication nonadherence. Strategies to target these beliefs when 
working with inner city patients can help setup goals relating to patient health education.  
Mann et al. encouraged further studies in relation to sociodemographics and other 
variables relating to anxiety, depression, alcohol abuse, and smoking. Mann et al. pointed 
out that regardless of the effectiveness of drug therapy, nonadherence continues to be a 
problem for health care providers. The Morisky scale showed validity and reliability in 
relation to medication adherence. The Morisky scale is made up of four questions relating 
to medication. The questions are answered using yes or no. Mann et al. described one 
example of a Morisky scale question: Do you ever forget to take your medicine? This 
scale was used by Mann et al. to prove adherence was more accurate than self-reporting 
by the patient. 
White et al. (2011) conducted a quantitative cross-sectional study using bivariate 
variables, the Spearman correlation coefficient, 15 questions in Spanish, and diabetes 
Type II specific numeracy measured by a diabetes numeracy test (DNT). The objective of 
the study was to see if there were any associations between the variables demographics, 
health literacy, diabetes-specific numeracy, acculturation, self-efficacy, self-care 
behaviors, and hbA1C levels. White et al. used the DNT to test for reliability and validity 
of the measurement tool never used in research. The participants of the study were 144 
Latinos with diabetes Type II. White et al. further detailed health literacy as opposed to 
quantitative literacy. Health literacy is described as the ability to understand and process 
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information provided regarding a person’s health to make appropriate decisions relating 
to health care. In a prior study, 400 English- and Spanish-speaking patients with diabetes 
Type II had lower health literacy associated with poor outcomes. The participants 
consisted of 62% females, 81% uninsured patients, 78% of Mexican Nationality, and 
96% with low level of acculturation. Quantitative literacy was described as being able to 
understand and process numbers. Understanding numbers from the authors’ perspective 
meant being able to calculate insulin accurately, count carbohydrates, calculate portion 
sizes from food labels, and being able to read the glucose meter when testing blood sugar. 
Patients who showed a low diabetes specific numeracy failed their physician 
recommendations having poorer outcome and nonadherence. Lower diabetes self-
efficacy in Latinos related to a lack of knowledge about diabetes Type II and limited 
knowledge about numeracy. White et al. used the Spearman correlation coefficient (p) 
values to test bivariate associations between DNT-15 Latino and sociodemographics, 
gender, nationality, language, education level, health history regarding diabetes Type II, 
including insulin. The DNT-15 Latino tool measurement is significantly associated with 
the construct measurement of health literacy, general numeracy, and diabetes-specific 
skills. Literacy is closely related to acculturation. Latinos were impacted by lack of 
acculturation, limiting adoption to health care, knowledge, and beliefs from the main 
culture (White et al. 2011). 
The new measurement tool used by White et al. (2011) lacked validity and 
reliability. The participants had no understanding of the DNT-15 tool, limiting the 
association between self-efficacy, self-care behaviors, and insulin use, including 
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glycemic control. White et al. called the limitations “floor effects” limiting the 
researchers' ability to accurately determine the correlation between the independent 
variables. White et al. determined that future research is needed in relation to 
sociodemographics, self-efficacy and self-care behaviors using a measurement tool that 
has validity and reliability. The sample size was limited to 144 participants, decreasing 
the accuracy of the study (White et al. 2011). 
White et al. (2011) discovered measurement information relating to glycemic 
control. White et al. used chart information and glucose testing at patient clinics 
providing information regarding the patient’s hbA1C. The patient’s cross-sectional study 
design provided information regarding the association between variables, their 
limitations, and weaknesses. The study emphasis was on health literacy and numeracy 
presenting data that can assist providers in understanding the patient’s limitations when 
conducting blood glucose tests. The information provided by the authors relating to 
diabetes-specific numeracy and acculturation was important when teaching the patient 
self-efficacy and self-care behaviors. Knowing that the patient is limited to diabetes-
specific skills alerts the provider to encourage health education promoting a better 
understanding of diabetes Type II disease processes and management (Mann et al., 2009). 
Nozaki et al. (2009) conducted a cross-sectional prospective study with stepwise 
multiple regression analysis using psychological tools to measure the association between 
psychological factors and glycemic control of participants with diabetes Type II. The 
study had 304 Japanese participants with diabetes Type II being managed at the 
outpatient clinics. All participants were required to take the hbA1C test. The participants 
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were also asked to complete the self-report psychological inventories: Diabetes 
Treatment Satisfaction Questionnaire (DTSQ), Problem Areas in Diabetes Survey 
(PAID), Well-Being Questionnaire 12 (W-BQ12), Self-Esteem Scale (SES), Social 
Support Scale, and Self-Efficacy Scale, and hbA1C measure 1 year later. Data were 
collected on demographics, age, and medical records. Nozaki et al. (2009) found that 
there was an association between age; diet management; microvascular problems of 
diabetes Type II; and the scores from the DTSQ, W-BQ12, PAID, SES, and the self-
efficacy scale. According to the stepwise multiple regression analysis, there was an 
association between the predictors at baseline hbA1C. The patients were followed for 1 
year. Two hundred and ninety participants (95.4% of the 304) were assessed after 1 year 
using the multiple regression analysis. Nozaki et al. (2009) determined that the DTSQ 
and the PAID predicted a lower hbA1C and medication adherence. 
The Nozaki et al. (2009) study had limitations relating to causal relationship 
between variables tested and glycemic control: a causal model was not used. Self-care 
and self-management were not correlated to medication adherence. Out of the 
participants, 14 were not easily followed and four patients passed away. The Nozaki et al. 
(2009) determined that the 14 patients were probably more dissatisfied with their 
treatment plan. Nozaki et al. could not determine if there were any differences between 
sociodemographics clinical or psychosocial variables after 1 year. 
The strengths of the Nozaki et al. (2009) study were the correlation between 
patient satisfaction and hbA1C control. Patient satisfaction denotes a better quality of life. 
Patients who are satisfied follow the physician’s recommendations and treatment regimen 
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plan. Nozaki et al. concluded that more regression analysis studies are needed in the 
future using sociodemographics, age, gender, and quality of life satisfaction. 
Boswell, Cook, Burch, Eaddy, and Cantrell (2010) completed a study using 
original research articles relating to medication adherence, clinical recommendations, 
economic, and use outcomes. The study included 13 chronic diseases. These diseases 
were coronary artery disease (CAD), hyperlipidemia, heart failure (HF), hypertension, 
postmyocardial infarction (post-MI), bipolar disorder, depression, schizophrenia, diabetes 
Type II, migraine, seizures, asthma, and chronic obstructive pulmonary disease (COPD). 
The variables of interest as described by the researchers were adherence, costs, outcomes, 
hospitalization, economics, and Medicaid, including persistence and prescription drugs. 
The data were collected from 1974-2010. Boswell et al. (2011) reviewed 105 articles 
dealing with the chronic diseases being evaluated except articles relating to migraine. 
Boswell et al. (2010) found that most of the articles showed a positive response to 
medication adherence, 64.3% to 100% depending on the categorical variables and the 
chronic disease. The highest level of positive outcomes related to post-MI, 
CAD/hyperlipidemia and schizophrenia. Diabetes, hypertension, and asthma showed a 
lower positive outcome but higher source of economic and use data.  
A limitation to the Boswell et al. (2010) study was based on the lacked of related 
studies to the identified chronic diseases and limited application of the plan research 
strategies. These limitations prevented a proper evaluation of medication adherence to 
diabetes, hypertension, asthma, and COPD. No literature was identified by researchers 
relating to the adherence of medication for migraines. Another limitation related to a lack 
48 
 
 
of individual variables dealing with adherence. The study emphasis was based on clinical 
interventions, use, and economic outcomes. The numerical level system used to label the 
literature reviewed became complex when there were limitations to the studies found on 
the chronic disease, such as migraine medication adherence (Boswell et al., 2010). 
Boswell et al. (2010) pointed out information in relation to the economic burden caused 
by chronic diseases and the use of these services with poor adherence to medication or 
physician recommendations. Medication adherence is a predictor of positive clinical 
outcomes, lower health care cost, and less use of services relating to complications. 
Boswell et al. recommended further studies related to independent variables that address 
a specific chronic disease, such as diabetes Type II. 
Mainous, Diaz, and Geeze (2008) analyzed data from 1999 – 2004 National 
Health and Nutrition Examination Survey (NHANES). The NHANES uses a complex, 
multistage, probability sampling design in selecting participants within the civilian 
population. Mainous et al. (2008) noted that the survey overly sampled population 
subgroups to increase the reliability and validity of determining health indicators 
representative of the population. Mainous et al. (2008) looked at acculturation; healthy 
lifestyle measures that included obesity, exercise, and diet; demographics characteristics; 
and access to care. The demographic characteristics were age, sex, poverty-income ratio 
(<1.0 versus >1.0), education, and access to care. Because of the complexity of the 
survey, Mainous et al. (2008) used the SUDAAN Statistical software, RTI international, 
Research Triangle Park, North Carolina to determine the weighting complex sampling 
design. Bivariate tests were conducted to measure the association between acculturation 
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by the SAS scores, country of birth, and lifestyle behaviors. Mainous et al. (2008) 
showed that 36% - 69% of individuals nationally were more acculturated. Latinos with 
diabetes Type II with less acculturation showed an annual income of less than $20,000 
and were less likely to have completed high school. The differences between diet and 
exercise were similar with the exception that less acculturated individuals exercised less 
during leisure time. The bivariate analysis on dietary fiber and cholesterol were similar 
between those who were acculturated and those who had less acculturation. The logistic 
regression analysis showed that acculturated individuals, as opposed to those who were 
less acculturated, were nonsmokers. Country of birth was not a strong indicator for a 
healthier life style; however, Latinos who had acculturated into the main stream had a 
better opportunity of health care access and better socioeconomic status (Mainous et al., 
2008).  
The cross-sectional data set from Mainous et al. (2008) limited the results’ ability 
to determine inferences regarding causal effects. Acculturation is significantly associated 
with many indicators relating to a healthy lifestyle; however, acculturation is a complex 
determinant due to the belief, values, and behaviors regarding health. The questions 
regarding physician and patients diagnosed with diabetes Type II does not indicate the 
recommendations given regarding the type of diagnosed diabetes. The information 
provided by Mainous et al. (2008) was limited regarding the Latino immigrants’ 
background characteristics. The survey provided limited information in relation to the 
Latinos’ adherence to medications (Mainous et al., 2008). Mainous et al. (2008) provided 
information in relation to patient access to care, culture, and acculturation in association 
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to patients with diabetes Type II adapting to new cultural values. Mainous et al. also 
pointed out that acculturation does not influence smoking or exercise. However, it 
influences adherence to medication and treatment plans.  
Rationale for Selection of the Variables and Concepts 
The variables and concepts of this study included nonadherence to diabetes Type 
II medications among Latinos in Fresno. The intent of the study was to determine 
predictors of nonadherence to diabetes Type II. It was an attempt to understand the 
following sociodemographic independent variables: age, gender, income, migrant status, 
health education, family size. The dependent variable was adherence to medications. The 
focus of the study was to understand people in their environment and how behaviors 
affect a person’s actions and habits. The study included concepts such as knowledge, 
skills, and the value placed on beneficial outcomes. 
Explanation of Controversial Variables 
Inconsistencies regarding the many variables researched were documented by the 
reviewed researchers. The inconsistencies and limitations were related to sample size, 
measurements tools used, and methodology design. The limitations in sociodemographic 
were related to the predictors and the type of specific independent and dependent 
variables measured. Another limitation was the minority groups that participated in the 
different studies, including the demographics: inner city versus rural areas. Wroth and 
Pathman (2006) noted that, regardless of the number of studies done, Latinos’ 
nonadherence to diabetes Type II medications is in a continuum and little is known about 
why patients fail to follow clinicians’ recommendations. Smith (2009) pointed out that 
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Afro-Caribbean and Latino descent patients are at a higher risk of diabetes Type II. The 
gap still exists in relation to sociodemographics and diabetes Type II affecting Latinos.  
The controversy found was in association to the philosophy of the researchers and 
clinicians. In their database search relating to diabetes Type II and racial ethnic 
minorities, Peek et al. (2007) found that two thirds of the studies were controlled trials or 
randomized controlled trials. Peek et al. proposed that more studies are needed relating to 
patients with diabetes Type II of racial, ethnic minority groups. The characteristics ought 
to relate to the patient’s characteristics, sociodemographics, education, and other 
variables that relate to the patient’s socioenvironment. 
Synthesize Studies Related to the Research Question 
The research question for the study related to sociodemographic predictors of 
medication nonadherence among Latinos with diabetes Type II. The review of the 
literature included only a few similar studies. However, these studies either had a 
different methodology, few variables, or a limited number of participants. The study 
related to Latinos with diabetes Type II in the Fresno. In a cross-sectional design study, 
the WHO (2003) found that medication adherence is related to socioeconomic status and 
poor communication between patients and providers. Mann et al. (2009) researched 
diabetes Type II using a multivariate analysis research design. Mann et al. predicted 
associations of medication nonadherence using a quantitative method of 131 participants. 
The variables included sociodemographics from the inner city, age, gender, employment, 
language, ethnicity, income, hbA1C, diabetes history, and comorbidity as reported by 
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patients. This study is closely related to the present study except with a few different 
variables and target population. 
Recommendations for Other Studies 
Fortmann, Gallo, and Phillis-Tsimikas (2012) and Peek et al. (2007) claimed that 
Latinos are disproportionately affected by diabetes Type II, have a higher prevalence of 
diabetes Type II, have higher hbA1C, and have an increased number of complications. 
Fortmann et al. discussed the importance of communication between patients and 
providers. It is equally important to provide avenues for social and environmental 
support, including resources required to manage this chronic health condition. Resources 
to manage diabetes Type II can be used to ensure medication adherence and prevent 
depression and anxiety. Rustveld et al. (2009) found that self-esteem and a sense of 
powerlessness can affect Latino American men with diabetes Type II. The data are 
important when referring Latino male patients to health education and other types of 
counseling.  
Mann et al. (2009) described predictors to diabetes Type II medications. Mann et 
al. added that the studies have been inconsistent in relation to target population, age, sex, 
ethnicity, income, education, and comorbidity. Mann et al. found that beliefs about 
causes and cures for diabetes Type II contribute significantly to the predictors of poor 
medication adherence. Mann et. also reported the importance of cultural sensitivity when 
tailoring educational classes to patients with diabetes Type II.  
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Social Impact Relating to Medication Nonadherence 
Horton (2012) described diabetes Type II complications as having a high impact 
on a patient’s quality of life. This quality of life is impacted by diabetes Type II 
complications, medication nonadherence, depression, limited access to care, and 
hospitalizations. Horton recommended understanding patients’ characteristics, their view 
of health care, and their understanding of the disease. The health care providers’ 
approach to patients will determine an effective positive outcome, including the patients’ 
social environment and cultural barriers (Horton, 2012). 
Cusi and Ocampo (2011) reflected on the importance of health care providers 
being aware of the need to tailor interventions for the Hispanic/Latino patient. According 
to Cusi and Ocampo, a gap exists between ethnic minorities in the United States. The 
Latino individual’s genetics is believed to influence diabetes Type II. Cusi and Ocampo 
found that, in 2009, Latinos had a higher prevalence of diabetes Type II as opposed to 
Caucasian patients. The prevalence of diabetes Type II for Latinos was 11.8% as opposed 
to 7.1% for Caucasian individuals. Awareness of patients’ needs, cultural beliefs, 
socioeconomic, and socioenvironmental barriers are important in order to plan 
interventions appropriate for them. Cusi and Ocampo recommended further studies 
relating to variables affecting Latino individuals. Improving positive outcomes ought to 
be the goal for clinicians and physicians. Therefore, adherence to medication, diet, and 
exercise is the triad for better diabetes Type II outcomes. 
Chan (2010) described medications nonadherence as a health care problem, 
impacting cost for the individual, family, and community. Chan (2010) estimated that 
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nonadherence is responsible for approximately $100 billion a year in health care costs. 
Health education is important not only for the health educators but for the health care 
providers as well to improve diabetes Type II adherences to medications.  
The CDC (2011) noted that the cost for diabetes care in the United States in 2007 
was $116 billion for medical expenses and an indirect cost of $58 billion for disability, 
work loss, and premature death. The CDC reported on complications such as heart 
disease as the cause of death in 68% of diabetes-related death. Strokes were noted to be 
16% of diabetes-related deaths. Other complications self-reported by patients with 
diabetes Type II included hypertension and diabetes. Blindness and eye problems were 
seen in individuals 20 to 74 years old in 2005 to 2008 during an examination of 4.2 
million (CDC, 2011). People with diabetes aged 40 or older had diabetes retinopathy, of 
these 655,000 had serious type of diabetic retinopathy. Kidney disease was reported on 
48,374 people with diabetes (CDC, 2011). 
The CDC (2011) reported that, in 2008, 2,002,290 people with diabetes and end-
stage kidney disease were living with regular dialysis or kidney transplants. Nervous 
system diseases were noted in 60% to 70% of individuals. These individuals had mild to 
severe nervous system diseases including carpal tunnel syndrome, impaired sensation, or 
pain in their feet. Erectile dysfunction and other nerve problems were noted as well. The 
CDC reported that, in 2006, 65,700 nontraumatic lower limb amputations were 
performed.  
Another problem with diabetes Type II is dental disease. Sanders-Polin (2012) 
described periodontal gum disease as a problem with diabetics. Nonadherence to diabetes 
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Type II medications increases the problem of periodontal gum disease due to poor 
glycemic control and vascular disease that affects nutrition responsible for the destructive 
inflammation of the gums. Poorly controlled diabetes Type II is the reason for the 
development of periodontal gum disease. Fried (2012) described the risk factors of 
periodontal disease that applies to many disorders including diabetes Type II. Individuals 
with diabetes Type II have a higher risk of developing gingivitis and periodontal disease.  
Periodontal disease impacts society, and patients. The literature was not specific to the 
cost to treat and manage diabetics with periodontal disease. However, Persson (2011) 
noted that periodontal disease is the sixth known complication for patients with diabetes 
Type II. The treatment of periodontal disease is associated with positive outcomes. 
Persson found that a person with diabetes Type II who is treated for periodontitis and has 
a hbA1C > 9.0% has an opportunity to decrease their hbA1C to 0.6% with no change in 
medication adherence, and patients with medication adherence have an opportunity to 
decrease their hbA1C to 1.4%. There is sufficient evidence that supports the impact of 
periodontal disease on systematic inflammation indicators (Persson, 2011).  
Literature Reviewed on Social Change 
There is a consensus among the investigators on medication adherence to prevent 
diabetes Type II complications. Nonadherence to medications is multifactorial in relation 
to race/ethnicity in minority groups. Latinos have many problems to overcome such as 
limited resources, limited access to care, and position value, including how the person 
views health. The benefits to medication adherence include glycemic control, less 
complications, better quality of life, increased productivity, decreased premature deaths, 
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and decreased disabilities related to diabetes Type II complications. The financial burden 
to health care will be decreased and patients with diabetes Type II will have an 
opportunity for patient satisfaction, decreasing depression, anxiety, and improved self-
esteem. The study will impact social change by improving patients’ diabetes Type II 
medication adherences and providing information to other health care providers about the 
importance of ensuring that Latino patients understand the recommendations. I aimed to 
improve policies at the state and community level relating to Latino patients barriers to 
medication adherence, including diet and exercise, by looking for associations among 
predictors specific to Latinos with diabetes Type II and nonadherences to medications. 
Swan (2010) explained that helping patients understand their barriers to diabetes 
management is important in preventing said barriers. Understanding why patients are not 
able to self-manage their diabetes is important for the patient, the family, and the health 
care provider. The independent predictors of nonadherence in this study were age, 
gender, income, migrant status, family size, and health education for patients with 
diabetes Type II. These variables were analyzed to help providers of care in 
understanding the factors associated with adherence. The social impact in decreasing 
cost, complications, improving quality of life, and patient satisfaction for both males and 
females is important to stockholders who finance health care for the uninsured, insurance 
payers, and state, including patients and families. The findings of this study could well 
assist in changing or improving national policies in relation to self-management of 
Latinos with diabetes Type II.  
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Summary and Conclusions 
This chapter included a description of diabetes Type II medication adherences 
versus nonadherence and research studies conducted to improve the management of 
diabetes Type II worldwide. The literature reviewed was a summary of the 
methodologies and designs used in the research studies, including the intervention 
conducted by different researchers to address the problem of nonadherences to 
medications. The review also included several theories relating to causes of diabetes 
Type II. The reviewed researchers suggested that social and environmental behaviors are 
contributing factors to diabetes Type II nonadherences. I also reviewed prior 
interventions to improve medication adherence through active patient participation and 
health education, diet, and exercise 
Chapter 3 will include detailed description of the methodology and research 
design, sample size requirements, participant recruitment, data analysis, and ethical 
considerations.      
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Chapter 3: Research Method 
Introduction 
A quantitative retrospective research study was conducted to understand the 
association between medication nonadherence among Latinos with diabetes Type II and 
the independent variables that included age, gender, income, migrant worker status, 
family size, and health education. These sociodemographic variables were used to predict 
an association to diabetes Type II medication adherence among Latinos. The dependent 
variable was adherence to diabetes Type II medications. A logistic regression analysis 
was used to quantify the association between variables. 
This chapter is divided into four sections. The introduction contains the 
description and purpose of the study. The research design and rationale connect the 
research questions with the research design. I define the research study, detailing the 
population, the sampling size, and how the information was collected when using 
archival data. It also contains the data analysis plan and how the data were interpreted.  
The methodology section includes a description of the power size, using the alpha level 
and power level of choice. The sections on threats to validity contain internal threats to 
validity, history, and statistical regression.  
Research Design and Approach 
This quantitative retrospective method design study was used to determine if there 
is an association between geographic characteristics of Latinos and the adherence to 
diabetes Type II medications. These characteristics included age, gender, income, 
migrant worker status, family size, and health education. The retrospective design was 
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used because the data were entered into database files at Clinica Sierra Vista, Fresno, 
California. Therefore, because the files contained existing data, the analysis was 
considered secondary. The archived database files at Clinica Sierra Vista are linked to i2i 
Media Tracks that services eight clinics from rural, suburban, and urban impoverished 
areas of the city. The data were pulled from January 2006 to December 2011 from the 
eight community health care center clinics. A series of bivariate analyses were conducted 
for each of the independent variables, determining an association between the 
independent variables and the dependent variable. A multivariate analysis was conducted 
to determine if combinations of significant variable together formed a strong predictor 
than the variable alone. 
Methodology 
Target Population 
The target population was limited to Latinos from eight clinics across Fresno, 
California with diabetes Type II. The general characteristics of the target population 
included individuals living in impoverished areas of the city, with limited resources, 
limited education, and income. The target population was comprised of a minimum of 
111 Latino patients as calculated using G*Power in the sample size and power 
calculation, see Selection of Participants below. The sample size was increased to 200 for 
oversampling. The ages of the participants were 18 years of age or older, males and 
females, who were working mainly as field workers. The i2i Media-Tracks database 
contains over 14,000 entries with information regarding medications, laboratory results, 
examinations, social and medical history, including random blood sugars or fasting blood 
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sugar performed during the medical visit. The 200 patients were selected from the 
database using a random number generator with a minimum of one and a maximum of 
14,000. 
Selection of Participants  
 The data were collected using secondary electronic medical record review. The 
participants were Latinos with diabetes Type II. The inclusion and exclusion criteria for 
qualifying patients from which data were gathered was males and females, 18 years of 
age or older, with diabetes Type II, patients of Clinica Sierra Vista, Community Health 
care Clinics, English- or Spanish-speaking. Patients were excluded if they had diabetes 
Type I, gestational diabetes, or diabetes insipidus. The retrospective quantitative research 
study data will be pulled from January 2006 to December 2011 for patients with at least 1 
year of diagnosis and treatment. 
Sample Size and Power Calculation 
The research study involved the use of one logistic regression and six independent 
variables. An effect size of 0.3 (medium) is generally an accepted range with a power of 
0.95 and an alpha of 0.01 after applying the Bonferroni adjustment (Franz, Edgar, Albert-
Georg, Axel, & Buchner, 2009). Given those values, the desired sample size to achieve 
empirical validity for the logistic regression with five predictors was a minimum of 111 
patients as calculated using the G*Power 3.1.7 calculator. A total of 200 patients were 
used as an oversampled size. LeBlanc and Fitzgerald (2009) described power as the 
probability that the results of the study will provide statistical analysis actions to evaluate 
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the hypotheses. Sample size is calculated using power to determine if the results are 
statistically significant (Franz et al., 2009).  
Characteristics of Selected Data 
The database files at Clinica Sierra Vista are linked to i2i Media Tracks that 
services eight clinics from rural, suburban, and urban impoverished areas of the city. The 
data were entered into IBM SPSS Statistics Software (Version 21). Descriptive statistics 
were conducted to describe the sample demographics, the research independent variables, 
and the dependent outcome variable nonadherence to medication among Latinos with 
diabetes Type II. Latinos were identified by race as specified in the demographics.  
Nonadherence was defined as a failure to comply with medication as prescribed, which 
included failure to take and/or refill their medication within at least a 6 month time frame. 
The data were collected from the electronic Medication record database files linked to the 
i2i Media Track or NextGen database. Frequency and percentages were calculated for 
gender, income, health education, family size, and migrant worker status by 
nonadherence to medications. Mean and standard deviations were calculated for age by 
nonadherence to medications. Depending on the predictors, an outcome action plan with 
recommendations to patient management and adherence to diabetes Type II medications 
was prepared. Results of the data analysis will be presented to both clinicians and staff in 
order for them to encourage patients to enter medication assistant programs, including 
free medication pharmaceutical programs available to patients with limited income. 
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Data Analysis 
The intent of the study was to determine if there are predictors of nonadherence to 
diabetes Type II medications using a quantitative method design. The objective of this 
research study was to understand the association between sociodemographic independent 
variables: age, gender, income, migrant worker status, family size, and health education. 
The dependent variable was adherence to medications among Latinos with diabetes Type 
II. A bivariate analysis for each independent variable was tested to see if there was an 
association between the independent variable and the dependent variable. The 
multivariate analysis method was used to identify strong predictor values of any 
combination of two independent variables in relation to diabetes Type II among Latinos. 
A logistic regression was conducted and is appropriate when the criteria variable 
is dichotomous with two possible outcomes. One variable can estimate the possibility of 
an event’s occurrence (Stevens, 2009). The dependent variable in this analysis was 
adherence to medications determined by whether or not a patient had refilled their 
medication within at least a 6 month time frame. The possible predictor variables tested 
in the analysis were age, gender, income, migrant worker status, family size, and health 
education. A logistic regression analysis can be used when the predictor variables are 
continuous, discrete, or a combination of continuous and discrete. Age was treated as a 
discrete variable, divided into four categories: 1=18 to 30 years of age, 2=31 to 45 years 
of age, 3=46 to 60 years of age, and 4=61 and older. Gender was categorized as males 
versus females, health education, yes versus no, and migrant worker status yes versus no. 
These were treated as dichotomous variables. Health education was determined by 
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whether or not the patient took diabetes Type II health education classes. Income was 
categorical dummy coded by the following classification 0= none, 1=$1 to $10, 000 per 
year, 2=$10,001 to $15,000 per year, 3=$15,001 to 20,000 per year, and 4=$20,001 or 
more.  Family size was defined by the number of persons per household. 
The logistic regression analysis permits the evaluation of the odds of membership 
in adherence versus nonadherence based on the combination of predictor variables. 
Overall model significance or the Omnibus test of model coefficients for the logistic 
regression was examined by the effect of the predictor variables on adherence to 
medication and were presented with an X² coefficient. The Cox and Snell R² and 
Nagelkerke R² were used to examine the percent of variance accounted for the predictor 
variables. Predicted probabilities of an event occurring were determined by the odds 
ratio, Exp (β; Tabachnick & Fidell, 2012). 
Logistic regressions overcome many of the restrictive assumptions of linear 
regressions. Linearity, normality, and equality of variances are not assumed, nor is it 
assumed that the error term variance is normally distributed. The major assumption of the 
logistic regression is that the outcome variable must be discrete. The data should not 
contain outliers, and there should be a linear relationship between the odds ratio and the 
predictor variables (Tabachnick & Fidell, 2012). If there are any outliers, they should be 
analyzed to determine if they represent unusual circumstances or if they are due to patient 
error. Linearity with an ordinal or interval predictor variable and the odds ratio can be 
checked by creating a new variable that divides the existing predictor variable into 
categories of equal intervals and running the same regression on these newly categorized 
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versions as categorical variables. Linearity is demonstrated if the B coefficient increases 
or decreases the linear steps (Garson, 2009). Finally, a large sample is recommended 
fitting with the maximum likelihood method; using discrete variables requires that there 
are enough responses in each category. Table 1 will present the inclusion and exclusion 
criteria for qualifying patients. 
 
Table 1 
Inclusion and Exclusion Criteria for Qualifying Patients From Which Data Were 
Gathered  
 
Inclusion  Exclusion  
1.  Patient of Clinical Sierra Vista 1. Patients with diabetes type I 
2.  Patients 18 years of age or older 2. Patients with gestational diabetes  
3.  Patients with diabetes type II 3. Diabetes insipidus 
4.  English or Spanish Speaking  
 
 
Variables, Descriptions, and Measurements 
 Inferential statistics were used to predict an association between the independent 
variables and the dependent variable: adherence to medications among Latinos with 
diabetes Type II. The omnibus test of coefficients for the logistic regression was 
examined by the effect of the predictor variables on adherences to medication and was 
presented with an X² coefficient. The data collected related to Latinos, which are defined 
as Mexican American, Mexican Migrant workers, Central American, South American, 
Puerto Ricans, Cubans, Portuguese, or any individual with a Hispanic background. The 
data were limited to patients who had identified their race as being Latino. 
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The data were entered into a SPSS version 21.0 for Windows. Descriptive 
statistics was conducted to describe the sample demographics and the research variables. 
Frequency and percentages were calculated for gender, income, health education, family 
size, and migrant worker status by adherence to medications. Means and standard 
deviations were calculated for age and income by nonadherence to medications. 
Screening of the data followed a statistical frequency distribution with cross tabulation 
(Broeck, Cunningham, Eeckels, & Herbst, 2005).  
Inferential Statistics 
All variables were examined using the overall model of significance, or the 
omnibus test of model coefficient, for the logistic regression and examined by the effect 
of the predictor variable on adherence to medication and were presented with an X² 
coefficient. The Cox and Snell R² and Nagelkerke R² were used to examine the 
percentage of variances accounted for by the Exp (β; Tabachnick & Fedell, 2012). The 
linearity with an ordinal, odds ratio and interval was used to determine if the B 
coefficient increases or decreases with the maximum likelihood method. 
Bivariate Analysis 
Bivariate analyses, followed by multivariate analysis, were conducted to 
determine an association between the independent variables and the dependent variable 
of nonadherence to medications. The independent variables were gender, age, income, 
health education, family size, and migrant worker status. The analyses were done in order 
to answer the question:  
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RQ1: Are there predictors of nonadherence to medications among Latinos with 
diabetes Type II? 
H01: There is not an association between age and nonadherence to medications 
among Latinos with diabetes Type II. 
Ha1: There is an association between age and nonadherence to medications among 
Latinos with diabetes Type II. 
H02: There is not an association between gender and nonadherence to medications 
among Latinos with diabetes Type II. 
Ha2: There is an association between gender and nonadherence to medications 
among Latinos with diabetes Type II. 
H03: There is not an association between income and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha3: There is an association between income and nonadherence to medications 
among Latinos with diabetes Type II. 
H04: There is not an association between migrant workers and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha4: There is an association between migrant workers and nonadherence to 
medications among Latinos with diabetes Type II. 
H05: There is not an association between family size and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha5: There is an association between family size and nonadherences to 
medications among Latinos with diabetes Type II.  
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H06: There is not an association between health education and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha6: There is an association between health education and nonadherence to 
medications among Latinos with diabetes Type II.  
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Table 2 
Diabetes Type II Medication Nonadherence Independent Predicted Bivariate Variables 
Null and Alternative Hypothesis (N=200) 
 
Hypothesis Concept Name of variable Possible outcome 
Ho1: 
There is not a statistically 
significant association between 
age and medication 
nonadherence among Latinos 
with diabetes type II. 
 
Ha1: 
There is a statistically significant 
association 
between age and medication 
nonadherence among Latinos 
with diabetes type II. 
 
Adherence to diabetes type II 
medications in relation to age 
groups. 
Continuous predictor is Age  An association might 
exist between age and 
medication non 
adherence in relation to 
Latinos with diabetes 
type II 
Ho2: 
There is no statistically 
significant association between 
gender and medication 
nonadherence among Latinos 
with diabetes type II. 
 
 
Ha2: 
There is a statistically significant 
association between gender and 
medication nonadherence among 
Latinos with diabetes type II. 
 
 
 
Adherence to diabetes type II 
medication for both males and 
females  
The predictor variable is gender 
  
There is or is not  
an association between 
gender in relation to 
adherences to diabetes 
type II medications 
among Latinos  
Ho3: 
There is no statistically 
significant association between 
income and nonadherences to 
diabetes type II medication  
 
Ha3: 
There is a statistically significant 
association between income and 
nonadherences to diabetes type II 
medications  
 
Medication adherence to 
diabetes type II regardless of 
income  
The predictor variable is income  
 
 
 
 
  
There is or is not an 
association between 
income and medication 
nonadherence among 
Latinos with diabetes 
type II. 
 
Ho4: 
There is no statically significant 
association between migrant 
worker status and nonadherences 
among Latinos with diabetes type 
II.  
 
Ha4: 
There is a statistically significant 
association between migrant 
worker and nonadherences 
among Latinos with diabetes type 
II. 
Medication adherence to 
diabetes type II in relation to 
migrant worker status  
The predictor variable is migrant 
worker status 
 
There is not 
a strong association 
between migrant worker 
status and nonadherence 
to diabetes type II 
medications among 
Latinos  
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Hypothesis Concept Name of variable Possible outcome 
Ho5: 
There is no statistically 
significant association between 
family size and nonadherences 
among Latinos with diabetes type 
II. 
Ha5: 
There is a statistically significant 
association between family size 
and nonadherences among 
Latinos with diabetes type II. 
 
Medication adherence to 
diabetes type II in relation to 
family size. 
 
 
 
  
The predictor variable is family 
size 
 
There is or is not an 
association between 
family size and 
adherences to diabetes 
type II medications  
Ho6: 
There is no statistically 
significant association between 
health education and 
nonadherences among Latinos 
with diabetes type II. 
Ha6: 
There is a statistically significant 
association between health 
education and nonadherences 
among Latinos with diabetes type 
II. 
Medication adherence to 
diabetes type II in relation to 
health education. 
 
 
 
  
The predictor variable is health 
education  
 
There is or is not an 
association between 
health education and 
adherences to diabetes 
type II medications  
 
Multivariate Analysis 
A multivariate analysis method was used to test the association between 
medication nonadherence and a combination of two predictors to diabetes Type II among 
Latinos.  
RQ2: Is there a combination of predictors to nonadherence to medications among 
Latinos with diabetes Type II? 
H07: The combination of age and gender is not a strong predictor of nonadherence 
to medications among Latinos with diabetes Type II. 
Ha7: The combination of age and gender is a strong predictor of nonadherence to 
medications among Latinos with diabetes Type II. 
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H08: The combination of migrant workers and income is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha8: The combination of migrant workers and income is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
H09: The combination of age and health education is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha9: The combination of age and health education is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
H010: The combination of income and family size is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha10: The combination of income and family size is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
H011: The combination of gender and health education is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha11: The combination of gender and health education is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
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Table 3 
Multivariate Variables (N=200) 
Hypotheses Concept Name of variable Possible outcome 
Ho7: 
There is not a strong association 
between the combination of age, 
gender and adherence to diabetes 
type II medications. 
Ha7:  
There is a strong association 
between the combination of age, 
gender and adherence to diabetes 
type II medications 
Age and gender in relation to 
adherence to diabetes type II 
medications. 
The combination variables are 
age and gender. 
There is or 
is not a 
strong 
association 
between 
diabetes 
type II and a 
combination 
of age and 
gender 
among 
Latinos. 
Ho8:  
The combination of migrant 
workers status and income are not 
strong predictors to adherence of 
diabetes type II medications. 
Ha8: 
The combination of migrant 
workers status and income are 
strong predictors to adherence of 
diabetes type II medications. 
Adherence to diabetes type II 
medications in relation to 
migrant worker status and 
income. 
The combination predictor 
variables are income and migrant 
worker status. 
There is or is not a 
strong predictor value 
associated with 
nonadherence to 
diabetes type II 
among Latinos.  
Ho9: 
Health education and age are not 
strong predictors to diabetes type 
II medication adherences. 
Ha9: 
The combination of health 
education and age are strong 
predictors to diabetes type II 
medication adherences. 
 
Health education and age in 
relation to diabetes type II 
medications. 
 
The combination predictor 
variables are health education and 
age. 
 
There is or is not a 
strong predictor value 
of the combined 
variables associated 
with adherences or 
nonadherences. 
 
Ho10: 
Family size and income are not 
strong predictors to diabetes type 
II medication adherences. 
Ha10: 
Family size and income are strong 
predictors to diabetes type II 
medication adherences. 
 
Family size and income in 
relation to diabetes type II 
medications. 
 
The combination predictor 
variables are family size and 
income. 
There is or is not a 
strong predictor value 
of the combined 
variables associated 
with adherences or 
nonadherences. 
Table Continues 
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Ho11:                                                                                   
Gender and health education are 
not strong predictors to diabetes 
type II medications adherences. 
Ha11:  
The combination of gender and 
health education are strong 
predictors to diabetes type II 
medication adherences  
Gender and Health education 
in relation to diabetes type II 
medications. 
 
 
The combination predictor 
variables are gender and health 
education 
There is or is not a 
strong predictor value 
of the combined 
variables associated 
with adherences or 
nonadherences. 
 
The independent variables were age, gender, income, health education, family 
size, and migrant worker status as predictors to medications nonadherence to be self-
completed and self-reported. These forms included personal information, demographics, 
resources, and medical history. The PSR are available to assist patients who speak 
languages other than English by providing translators. The information collected was 
stored using “i2i Media Tracks.” The staff is trained to treat the data collected with the 
upmost sensitivity and confidentiality, regardless of patient’s insurance or income status.  
The patient’s information is maintained using the Health Insurance Portability and 
Accountability Act of 1996. The data are self-reported by the patient at the time of the 
medical visit. Once the information is in the system, the data are updated at time of each 
recurrent visit by the trained staff at Clinica Sierra Vista in Fresno, California.  
Table 4 
 Omnibus Test of Model Coefficient Using SPSS 
 Chi-Square df Sig 
Step 1    Step 
              Block 
              Model 
Numbers 
Numbers 
Numbers 
 
5 
5 
5 
 
.000 
.000 
.000 
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Table 5 
Model Summary  
Step .2 Log Likelihood Cox & Snell R² Nagelkerke R² 
  1      Numbers    Numbers     Numbers 
       
Table 6 
Variables in Model 
 B   SE  Wald   df    Sig      Exp (β) 
Step 0  1 ( )   ( )   ( )    1   ( )   ( ) 
 
Data Analysis Matrix 
The data are stored on servers at Clinica Sierra Vista. The “i2i Media Tracks” 
contains over 14, 000 active patients suffering from diabetes Type II. The majority of the 
population was Latinos from the different areas of Fresno. There are eight clinics in 
Fresno servicing the community. A letter permitting use of Clinica Sierra Vista data files 
were authorized by the administrators (see Appendix A). The administrators have been 
helpful as long as patient confidentiality is maintained. See Table 7: 
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Table 7 
Analysis Matrix for the Quantitative Retrospective Research Study Between Medications 
Nonadherences Among Latinos With Diabetes Type II (N = 200) 
 
Study  Concept   Data   Measurement  Data analysis 
and statistics  
I Study of population 
adherences to 
diabetes type II 
medications 
Medical chart 
review and 
electronic 
medical record 
review 
Ordinal, 
quantitative, 
dichotomous, 
continuous, 
categorical 
Mean, standard 
deviation, 
percentage and 
frequency 
 
I.1 Study of 
demographics of 
individuals in 
relation to adherence 
to diabetes type II 
medication 
Medical chart 
review and 
electronic 
medical record 
review 
Ordinal, 
quantitative, 
dichotomous, 
continuous, 
categorical  
Mean, standard 
deviation, 
percentage and 
frequency 
 
I.2 Study of a 
combination of 
demographics in 
relation to adherence 
to diabetes type II 
medication 
Medical Chart 
review and 
electronic 
medical record 
review 
Ordinal, 
quantitative, 
dichotomous, 
continuous, 
categorical  
Mean, standard 
deviation, 
percentage and 
frequency 
 
 
Threats to Validity 
 The use of quantitative retrospective design archive data leads to threats to 
external validity (Garcia-Perez, 2012). Gathering the right sample is important in order to 
determine the accuracy of the population with diabetes Type II among Latinos.  
Historical accuracy of the data collected will decrease the threat to external and internal 
validity, increasing the reliability of the data. Therefore, the research study reliability will 
improve the possibility of providing programs to help Latinos with diabetes Type II in 
Fresno, California. 
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 Statistical regression is a possible threat to interval validity with a nonrandom 
sample, such as in the case of secondary data analysis and two measurements that have 
no association. In this phenomenon, the statistical regression occurs causing a threat to 
the internal validity and reliability of the study (Weisstein, 2013). Accuracy of the data 
may also be skewed by the possibility of patients providing inaccurate data due to reasons 
such as distractions from other patients in the same room, feeling rushed in order to see a 
physician sooner, and trying to protect their reputation in their community. 
Ethical Procedures 
Clinica Sierra Vista provided a letter granting access to the archival data on 
September, 2012. The letter was signed by the deputy chief of programs and by the chief 
administrative officer, permitting the use of the aggregate data containing over 14,000 
active patients suffering from diabetes Type II. The database contains a lot of data with 
multiple variables including, but not limited to patients’ demographics, principal 
language spoken at home, and income. Clinica Sierra Vista as a stakeholder was 
committed to the success of the research study. See permission letter (Appendix A). All 
data were recognized as requiring confidentiality under the Health Insurance Portability 
and Accountability Act (HIPAA) and the National Institute of Health (NIH) web-based 
training course Protecting Human Research Participants (Appendix B) certificate of 
completion dated 9/24/2011. This requirement was met fully including Clinica Sierra 
Vista policies and procedures relating to patient confidentiality. The data gathered did not 
include names of patients pulled for research. All identifiers were removed from the 
database. The data were collected from the “i2i media tracks” electronic medical records.  
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Walden University requirements were met. The data collected were archived data 
from Clinica Sierra Vista database files. There was no risk to the participants. No data 
analysis was performed or collected without the IRB approval. Once permission was 
given, the data were entered into the electronic SPSS software. Once the data were 
entered, it will be managed with the outmost integrity and accuracy and deleted after 6 
years using a Zip archive folder to protect the files. I submitted an IRB application as per 
university regulations.  Data was collected after given IRB approval to conduct the study 
(Walden IRB approval number is 02-26-14-0182422). 
Summary 
Chapter 3 contains information relating to the research design, the methodology, 
the population, sample size, and data collection. The chapter also includes information 
regarding internal as well as external threats to validity, accuracy, and data integrity.  
Another area discussed in this chapter relates to permissions and requirements when 
working with archived data, protection of human subjects, and IRB approval for data 
analysis. Chapter 4 will include the data collection, analysis, and interpretation of the 
data. 
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Chapter 4: Results  
Introduction 
The purpose of the research study was to understand the barriers to medication 
nonadherence among Latinos with diabetes Type II using the independent variables of 
age, gender, income, migrant worker status, family size, and health education. These 
sociodemographic variables may predict an association to diabetes Type II medication 
adherence among Latinos (the dependent variable). The research questions and 
hypotheses were as follows: 
RQ1: Are there predictors of nonadherence to medications among Latinos with 
diabetes Type II? 
H01: There is not an association between age and nonadherence to medications 
among Latinos with diabetes Type II. 
Ha1: There is an association between age and nonadherence to medications among 
Latinos with diabetes Type II. 
H02: There is not an association between gender and nonadherence to medications 
among Latinos with diabetes Type II. 
Ha2: There is an association between gender and nonadherence to medications 
among Latinos with diabetes Type II. 
H03: There is not an association between income and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha3: There is an association between income and nonadherence to medications 
among Latinos with diabetes Type II. 
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H04: There is not an association between migrant workers and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha4: There is an association between migrant workers and nonadherence to 
medications among Latinos with diabetes Type II. 
H05: There is not an association between family size and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha5: There is an association between family size and nonadherence to 
medications among Latinos with diabetes Type II.  
H06: There is not an association between health education and nonadherence to 
medications among Latinos with diabetes Type II. 
Ha6: There is an association between health education and nonadherence to 
medications among Latinos with diabetes Type II.  
RQ2: Is there a combination of predictors to nonadherence to medications among 
Latinos with diabetes Type II? 
H07: The combination of age and gender is not a strong predictor of nonadherence 
to medications among Latinos with diabetes Type II. 
Ha7: The combination of age and gender is a strong predictor of nonadherence to 
medications among Latinos with diabetes Type II. 
H08: The combination of migrant workers and income is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha8: The combination of migrant workers and income is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
79 
 
 
H09: The combination of age and health education is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha9: The combination of age and health education is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
H010: The combination of income and family size is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha10: The combination of income and family size is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
H011: The combination of gender and health education is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Ha11: The combination of gender and health education is a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. 
Chapter 4 is divided into four sections. The introduction contains a brief 
description of the purpose, research questions, and hypotheses. The data collection 
includes the timeframe, variables, and types of analysis that was done. The results include 
data analysis and findings consisting of descriptive and inferential statistics. The results 
include bivariate and multivariate analysis. In the summary, I answer the research 
question and prescriptive material. 
Data Collection 
The study was a quantitative retrospective data method design. I conducted a 
secondary data analysis performed from the database files at Clinica Sierra Vista linked 
to i2i Media Tracks that serves eight clinics from rural, suburban, and urban 
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impoverished areas of the city. The data gathered were from 2010 to 2014. The data were 
collected and analyzed between March and May 2014. The data were analyzed to 
understand the association between the sociodemographic independent variables of age, 
gender, income, migrant status, family size, and health education, including the 
dependent variable adherence to medications among Latinos with diabetes Type II. A 
bivariate analysis for each independent variable was tested to see if there was an 
association between the independent variables and the dependent variable. The 
multivariate analysis method identified strong predictor values of any combination of the 
six independent variables in relation to diabetes Type II among Latinos. The original plan 
was to analyze data varying from 2008 to 2012; however, I found that there were 
insufficient electronic data available prior to 2010. The number of patients from 2008 and 
2009 combined were less than 40; however, it was specified that 40 patients per year over 
a 5-year span was necessary to equate to 200 patients for this study. Therefore, the study 
was adjusted to include data spanning from 2010 to 2014. As the data were analyzed, it 
was noted that family size could have had an impact on how income is dispersed within a 
household. Family size was thus added as an additional independent variable. 
Study Sample  
Descriptive statistics analysis was conducted to describe the sample demographics 
and the research variables. Frequency and percentages were calculated for age, gender, 
income, health education, family size, and migrant worker status by nonadherence to 
medications. Means and standard deviations were calculated for age and income by 
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nonadherence to medications. Screening of the data followed a statistical frequency 
distribution with cross tabulation (Broeck et al., 2005).  
Results 
The frequencies and percentages related to diabetes Type II from highest to 
lowest by age was 46 to 60 years of age, 31 to 45 years of age, 60 years and over, and 18 
to 30 years of age. Diabetes Type II was less frequent among younger people in the 
sample. The distribution of the subjects with diabetes Type II by gender was females 
70% and males 30%. Frequencies of patients with diabetes Type II by the independent 
variable income was described from highest to lowest $1.00 to $10,000, followed by 
$10,001 to $15,000, $20,001 and over, and lastly $15,001 to $20,000. The frequency of 
income could be affected by the fact that the majority of residents of Fresno County are 
impoverished and under the federal poverty level according to the 2012 guidelines. 
Specifically, 79.5% of patients were migrant workers versus 20.5% who were not. This 
correlates with frequencies of income; migrant workers tend to be more impoverished. I 
found that 65.5 % of patients took health education classes whereas 34.5% did not. 
Patients’ family size ranked highest to lowest were families with two to four members, 
one member, and five or more members in the home. Table 8 presents the demographics 
of the population. 
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Table 8 
Frequency and Percent Distribution of Selected Demographic Characteristics of the 
Study Subjects Using the SPSS (N = 200) 
 
Category Frequency Percentage 
Age   
18-30 7 3.5 
31-45 51 25.1 
46-60 92 46.0 
61-over 50 25.0 
Total 200 100 
Gender   
Males 60 30 
Females 140 70 
Total 200 100 
Income   
1-10,000 86 43.0 
10,000-15,000 57 28.0 
15,001-20,000 19 9.5 
20,000+ 38 19.0 
Total 200 100 
Migrant worker status   
Yes 159 79.5 
No 41 20.5 
Health education   
Yes 131 65.5 
No 69 34.5 
Total 200 100 
Family size   
1 
2 - 4  
5 and up 
 
69 
92 
39 
34.5 
46 
19.5 
Total 200 100 
 
Rates of medication nonadherence for patients diagnosed with diabetes Type II 
among Latinos were almost evenly distributed as 53.5% who adhered versus 46.5 % who 
did not adhere among Latinos with diabetes Type II. See Table 9 and Table 10: 
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Table 9 
Frequency and Percent Distribution of Medications Nonadherence Among Study Subjects 
(N = 200) 
 
                                     Frequency                 Percentage 
Medication nonadherence 
 No                                                 93                                                 46.5 
 Yes                                              107                                                 53.5 
Total:         200                  100.0 
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Table 10 
Bivariate Omnibus Test Results Using SPSS (N=200) 
 df X² Cox & 
Snell R² 
Nagelkerke 
R² 
P OR 
 
Age & 
nonadherence 
4 .279 .001 .002 .598 .911 
Gender & 
nonadherence 
1 7.734 .038 .051 .005* .413 
Income & 
nonadherence 
4 .001 .000 .000 .982 1.003 
Migrant 
worker & 
nonadherence 
1 .001 .000 .000 .982 1.008 
Health 
education & 
nonadherence 
1 4.510 .022 .030 .034* 1.900 
Family Size & 
nonadherence 
3 .952 .005 .006 .329 .869 
Note. Odds ratios were calculated using a 95% confidence interval. An alpha level of 
0.05 was used 
 *Shows a moderate association to nonadherence to medications among Latinos with 
diabetes Type II.  
 
Research Question 1 
1. Are there predictors of nonadherence to medications among Latinos with 
diabetes Type II? 
The odds ratio for the association between age and nonadherence to medications 
was calculated to 0.911 with a p value of 0.598. For the age group 18 to 30 years, 85.7% 
of patients did not adhere and 14.3% adhered to medications (n = 7; 3.5%). For the age 
group 31 to 45 years, 53.9% showed nonadherence to diabetes Type II medications and 
47.1% adhered to medications (n = 51; 25%). Patients between the ages of 46 to 60 had 
an adherence rate of 50% and a nonadherence rate of 50% to medications (n = 92; 
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25.5%).  Patients 60 years of age and older showed an adherence of 44% and a 
nonadherence rate of 56% to medications (n = 50; 25.0%). I accepted the null hypothesis 
because the p value is significantly greater than 0.05. There is not an association between 
age and nonadherence to medications among Latinos with diabetes Type II. 
The odds ratio for the association between gender and nonadherence to diabetes 
Type II medications among Latinos was calculated to 0.413 with a p value of 0.005. 
Because the p value calculated is less than 0.05, I rejected the null hypothesis. There is an 
association between gender and nonadherence to medications among Latinos with 
diabetes Type II. 
The odds ratio for the association between income and nonadherence to diabetes 
Type II medications among Latinos was calculated at 1.003 with a p value of 0.982. 
Income was divided into four categories. The categories were chosen starting at $1 to 
$10,000 and incrementing $5,000 per category to represent the 2012 Federal Poverty 
Measurements of the impoverished areas in Fresno County. The first category $1 to $10 
000 showed adherence of 47.7% and nonadherence of 52.3% (n = 86; 43%). The second 
category $10,000 to $15,000 showed a medication adherence of 42.1 % and 
nonadherence of 57.9% (n = 57; 28.5%). The third category $15,000 to $20,000 showed a 
statistical analysis of medication adherence of 57.9% and a medication nonadherence of 
42.1% (n = 19; 9.5%). The fourth category included $20,000 and over and showed 
statistical analysis for medication adherence of 44.7% and nonadherence of 55.3% (n = 
38; 19%). The p value calculated greater than 0.05. Therefore, I accepted the null 
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hypothesis.  There is no association between income and nonadherence to medications 
among Latinos with diabetes Type II. 
The odds ratio in association to migrant worker status and nonadherence to 
diabetes Type II medications among Latinos with diabetes Type II was calculated to 
1.008 with a p value of 0.982. The p value calculated greater than 0.05. Therefore, I 
accepted the null hypothesis. There is not an association between migrant worker status 
and nonadherence to medications among Latinos with diabetes Type II. 
The odds ratio in association to family size and nonadherence among Latinos with 
diabetes Type II calculated to 0.869 with a p value of 0.329.  Family size was grouped by 
individuals per household. Groups were divided as one person, two to four persons, and 
five or more persons. A family size of one had a medication adherence of 42% and a 
medication nonadherence of 58% (n = 69; 34.5%). A family size of two to four persons 
had a medication adherence of 48% and a medication nonadherence of 52% (n = 92; 
46%). A family size of five or more had a medication adherence of 51% and a medication 
nonadherence of 49% (n = 39; 19.5%).  The p value is greater than 0.05. Therefore, I 
accepted the null hypothesis. There is no association between family size and 
nonadherence to medications among Latinos with diabetes Type II. 
The odds ratio in association to health education and nonadherence to diabetes 
Type II medications calculated to 1.900 with a p value of 0.034. The p value is less than 
0.05. Therefore, I rejected the null hypothesis. There is an association between health 
education and nonadherence to medications among Latinos with diabetes Type II. See 
Table 11: 
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Table 11 
Multivariate Omnibus Test Results for all Variables Using SPSS (N=200) 
                Df                p             OR 
Age 4 .745 1.063 
Gender 1 .012 2.301 
Income 4 .995 1.001 
Migrant worker 1 .967 1.015 
Health education 1 .049 .538 
Family size 3 .329 .869 
Constant  1 .237 .441 
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Table 12 
Multivariate Omnibus Test Results for Combinations of Variables (N=200) 
 df Wald X² Cox & 
Snell R² 
Nagelkerke 
R² 
p OR 
Age, gender & 
nonadherence 
2 .064 
7.191 
7.798 .038 .051 .020* .955 
.417 
Migrant worker, 
income & 
nonadherence 
2 .001 
.001 
.001 .000 .000 .999 1.003 
1.009 
Age, health 
education & 
nonadherence 
2 .261 
4.397 
4.771 .024 .031 .092 .912 
1.898 
Income, family 
size & 
nonadherence 
2 .219 
1.165 
1.172 .006 .008 .323 
 
.937 
1.265 
Gender, health 
education & 
nonadherence 
2 6.991 
3.998 
11.809 .057 .077 .003* .420 
1.862 
Note. Odds ratios were calculated using a 95% confidence interval. An alpha level of 
0.05 was used.*Shows a strong association to nonadherence to medications among 
Latinos with diabetes Type II. Odds ratios were calculated using a 95% confidence 
interval.  
 
Research Question 2 
2. Is there a combination of predictors to nonadherence to medications 
among Latinos with diabetes Type II? 
The combination of age and gender is a strong predictor to nonadherence to 
medications among Latinos with diabetes Type II. The odds ratio was calculated at 0.955 
and gender at 0.417 with a p value of 0.020. Because the P value is less than 0.05, I 
rejected the null hypothesis. The combination of age and gender is a strong predictor to 
diabetes Type II medications among Latinos. 
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The odds ratio between migrant worker status and income as a predictor to 
medication nonadherence among Latinos with diabetes Type II was calculated at 1.009 
for migrant workers and at 1.003 for income with a p value of 0.999. The p value is 
greater than 0.05. Therefore, I accept the null hypothesis. There is not a strong 
association between migrant worker status and income associated with diabetes Type II 
among Latinos. 
The odds ratio for the combination of age and health education was calculated at 
.912 for age and 1.009 for health education with a p value of 0.092 greater than the 
normal p value of 0.05. Therefore, I accepted the null hypothesis. The combination of age 
and health education is not a strong predictor of nonadherence to medications among 
Latinos with diabetes Type II.  
The combination of income and family size is not a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. The odds ratio was 
calculated for income at 0.937 and at 1.265 for family size with a p value of 0.323 greater 
than the normal p value of 0.05. Therefore, I accepted the null hypothesis. There is no 
association between the combination of income and family size and nonadherence to 
medications among Latinos with diabetes Type II. 
The odds ratio for the combination of gender and health education was calculated 
at 0.420 for gender and 1.862 for health education with a p. value of 0.003. Because the 
value is less than the normal p value of 0.05, I rejected the null hypothesis. The 
combination of gender and health education is a strong predictor of nonadherence to 
medications among Latinos with diabetes Type II, rejecting the null hypothesis. 
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Summary 
 I found that gender is the only strong predictor of nonadherence to medications 
for Latinos with diabetes Type II. Out of the patients who were randomly selected, the 
majority of them were women, which could pose as a limitation to the study. However, a 
higher percentage of women adhered to medications as compared to the percentage of 
men who adhered. Further investigation would have to be done as to why women are 
more likely to adhere than men. The combination age, gender and gender, health 
education proved to be strong predictors to nonadherence to medications for Latinos with 
diabetes Type II.  Chapter 5 includes the interpretation of the findings, limitations of the 
study, and recommendations. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of the research study was to explore the association between the 
dependent variable adherence to medications among Latinos with diabetes Type II and 
the sociodemographics independent variables age, gender, income, migrant worker status, 
family size, and health education to determine if there are predictors of nonadherence to 
diabetes Type II medications among Latinos with diabetes Type II. I analyzed the data 
from 200 males and females patients 18 years of age and older diagnosed with diabetes 
Type II from a clinic linked to i2i Media tracks that serves eight clinics from rural, 
suburban, and urban impoverished areas of the city. The research was guided using the 
SDT and the social cognitive theory. The independent variable showed that health 
education and gender each showed an association with medication nonadherence among 
Latinos with diabetes Type II compared to the other variables when a p value threshold of 
.05 was employed; however, after applying the Bonferroni adjustment value, they proved 
to be significant only when studied in combination. 
Interpretation of the Findings 
RQ1: Are there predictors of nonadherence to medications among Latinos with 
diabetes Type II?  
Finding 1: Age and Nonadherence 
I found that there was no association between age and nonadherence to 
medications among Latinos with diabetes Type II. The adherence rates were 46.5% 
among Latinos with diabetes Type II with a nonadherence rate of 53.5%. For the age 
group 18 to 30 years, 85.7% of patients did not adhere and 14.3% adhered to medications 
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(n = 7; 3.5%). For the age group 31 to 45 years, 53.9% showed nonadherence to diabetes 
Type II medications and 47.1% adhered to medications (n = 51; 25%). Patients between 
the ages of 46 to 60 had an adherence rate of 50% and a nonadherence rate of 50% to 
medications (n = 92; 25.5%). Patients 60 years of age and older showed an adherence of 
44% and a nonadherence rate of 56% to medications (n = 50; 25.0%). The average age of 
individuals with diabetes type II among Latinos was calculated at 54.7 years of age. The 
statistical analysis for the combined test model showed that there is not a significant 
association between age and nonadherence to medications among Latinos with diabetes 
Type II. The overall Omnibus Test of Model Coefficients yielded an overall (chi-square = 
0.279; p = .598; OR = .911).  The overall Omnibus Test of Model Coefficient Odds Ratio 
was .911 and the p value was .598. Therefore, there was no association between age and 
nonadherence to medications among Latinos with diabetes Type II. Nozaki et al. (2009) 
found that there was an association between age and medication adherence. However, 
Nozaki et al. did not include a percentage distribution of age groups, making it difficult to 
compare the statistical findings per age group. Among the age groups, there was a 
correlation between age and nonadherence to medications. The p value was greater than 
0.05 and the odds ratio was .911, which indicates that there was no association to the 
outcome adherence.   
Finding 2: Gender and Nonadherence 
 There was a weak to moderate association between gender and nonadherence to 
medications among Latinos with diabetes Type II. The overall omnibus test of Model 
Coefficients for gender yielded a (chi-square = 7.734; p =  0.005; OR = 0.413). Males 
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showed an adherence rate of 31.7% and a nonadherence rate of 68.3% (n = 60; 30%). I 
found that the male gender nonadherence was high. The adherence rate for females was 
52.9% to medications among Latino females with diabetes Type II and a nonadherence 
rate of 47.1% (n = 140; 70%). The results of the study indicate that there is an association 
to the outcome variable of adherence and a weak association between gender and 
nonadherence between medications among the Latino female group. The study resulted in 
70% of participants being female and 30% males. This mirrors the distribution of gender 
for patients studied by Mann et al. (2009) who reported that 68% of patients in the study 
were female. Mann et al. was also not able to conclude a strong correlation between 
gender and medication nonadherence among Latinos with diabetes Type II. White et al. 
(2011) used the Spearman correlation coefficient (p) values to test bivariate associations 
between DNT-15 Latino and sociodemographics, gender, nationality, language, education 
level, and health history regarding diabetes Type II, including insulin. The DNT-15 
Latino tool measurement was significantly associated with females generally being more 
likely to seek out medical care than males. Giving these findings, it may be worth 
investigating ways to encourage males to seek medical attention through national 
campaigns or public announcements. It is important to find alternative means to motivate 
the male Latino patient with diabetes to improve adherence to medications, diet, and 
exercise. Rustveld et al. (2009) found that self-esteem and a sense of powerlessness can 
affect Latino American men with diabetes Type II. 
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Finding 3: Income and Nonadherence 
 I found that there was not a significant association between income and 
nonadherence to medications among Latinos with diabetes Type II. The overall Omnibus 
Test of Model Coefficients for income yielded a (chi-square = 0.001; p = .982; OR = 
1.003).   The overall adherence rate was 46.5% and medication nonadherence 53.5%.   
The average income was calculated at $10,225.  Categories were chosen starting at $1 to 
$10,000 and incrementing $5,000 per category to represent the 2012 Federal Poverty 
Measurements of the impoverished areas in Fresno County. The first category $1 to $10, 
000 showed adherence of 47.7% and nonadherence of 52.3% (n = 86; 43%). The second 
category $10,000 to $15,000 showed a medication adherence of 42.1 % and a 
nonadherence of 57.9% (n = 57; 28.5%). The third category $15,000 to $20,000 showed a 
statistical analysis of medication adherence of 57.9% and medication nonadherence of 
42.1% (n = 19; 9.5%). The fourth category included $20,000 and over and showed 
statistical analysis for medication adherence of 44.7% and nonadherence of 55.3% (n = 
38; 19%).  Income and nonadherence p value .982 and the OR value 1.003 indicate that 
there is not an association to income and nonadherence to medication among Latinos 
with diabetes Type II. The OR is closer to 1, however, the p value is greater than 0.05.  
The OR results of 1.003 indicate that there is a weak association to the outcome 
adherence. Hence, the research findings are similar to the research study conducted by 
Mann et al. (2009) who reported the predictor income and found it to be inconsistent due 
to variations in study designs and sample populations. Mann et al. reported that 89% of 
participants had an income level of less than $30,000.  Mainous et al. (2008) found that 
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Latinos with diabetes Type II with less acculturation showed an annual income of less 
than $20,000 and were less likely to have completed high school. The studies are similar 
to the income distribution in this study where 81% of participants had an income level 
less than $20,000. Thus, this finding correlates to what Mann et al. and Mainous et al. 
had previously demonstrated. The study population consisted of individuals from 
impoverished areas of Fresno County who traveled to different areas of the state and to 
other states looking for employment as migrant farm workers. Many of these individuals 
have a difficult time meeting their daily health care and medication responsibilities.   
Finding 4: Migrant Worker Status and Nonadherence 
 There was not a significant association between migrant worker status and 
nonadherence to medications among Latinos with diabetes Type II. The overall Omnibus 
Test of Model coefficients yielded a (chi-square = .001; p = .982; OR = 1.008). Migrant 
worker status statistical analysis showed an adherence of 46.5% and nonadherence of 
53.5% (n = 159; 79.5%). Migrant worker status did not show a statistical significance to 
medication nonadherence. This finding is surprising because migrant workers travel from 
state to state for extended periods of time within the year, making it difficult to get their 
medications when out of the residency state. I have observed that some migrant workers 
will plan ahead to ensure that they have sufficient medications while they are away, 
requesting a 90-day supply of medication. However, they might run out of medication if 
their assignment is for more than 6 months, or they might still forget to take their 
medications while they are away. Migrant worker status was not identified in the 
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literature. Therefore, further research is needed to explore motivational means of 
increasing adherence among Latino male migrant workers with diabetes Type II. 
Finding 5: Family Size and Nonadherence 
There was not a significant association between family size and nonadherence to 
medications among Latinos with diabetes Type II. The overall Omnibus Tests of Model 
Coefficients rate for family size yielded a (chi-square = .952; p = .329; OR = .869). The 
overall logistic regression results for family size was medication adherence 46.5% and 
medication nonadherence was 53.5%.  A family size of one had a medication adherence 
of 42% and a medication nonadherence of 58% (n = 69; 34.5%). A family size of two to 
four had a medication adherence of 47.8% and a medication nonadherence of 52.2% (n = 
92; 46%). A family size of five or more had a medication adherence of 51.3% and a 
medication nonadherence of 48.7% (n = 39; 19.5%). The family size and nonadherence p 
value was .329 and the odds ratio was .869. The values indicate that there was no 
association to the outcome adherence. There has been no previous study on the 
correlation of family size to medication nonadherence among Latinos with diabetes Type 
II. Based on the results of this study, family size may be included as a predictor variable 
in future research studies.  
Finding 6: Health Education and Nonadherence 
Health education had a statistical association to nonadherence to medications 
among Latinos with diabetes Type II prior to applying the Bonferroni adjustment. When 
using the alpha value .05, the results showed a p value of .034 with an odds ratio of 1.9, 
which may indicate that there is a strong association.  The Omnibus Tests of Model of 
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coefficients was (chi-square = 4.510; p = .034; OR = 1.900). Patients who had health 
education classes had an overall adherence rate of 51.9% and a nonadherence of 48.1% (n 
= 131; 65.5%). Out of the 200 patients, 69 did not attend the educational classes and 131 
patient attended health educational classes. Patients who take education classes are 
probably more likely to adhere to medications. Mann et al. (2009) reported that health 
education from the participants’ point of view was not given in a way they could 
understand or comprehend what was being taught. Because this might have been the case 
in this study, it may be worth the effort to alter the ways health education is provided to 
patients with language barriers, limited education, limited knowledge of diabetes Type II, 
and limited resources including transportation and health care insurance so that more 
patients can have access to health education. Patients should also be encouraged to bring 
family members to the health educational classes in order to remind them or aid in their 
understanding of what has been taught. Health education awareness is important in 
patients self-managing diabetes Type II, which includes blood glucose testing, 
understanding of how to take by mouth medications or inject insulin, knowing critical 
blood glucose levels results, and sticking their finger to find blood glucose level before 
and after a meal. The WHO (2003) noted that health education is not only for patients but 
clinicians as well to be able to deliver similar protocols where both the clinician and the 
patient are ready for adherence supported by a health delivery system. 
Finding 7: Age, Gender, and Nonadherence 
The combination of age and gender were strong predictors to medication 
nonadherence among Latinos with diabetes Type II using the alpha p value of .05. The 
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Logistic Regression Omnibus Tests of Model Coefficients statistic analysis yielded an 
overall (chi-square = 7.798; p = 0.020; OR = 0.955/0.417). Nozaki et al. (2009) reported 
that more logistic regression analysis studies are needed in the future using 
sociodemographics, age, and gender. The results of this finding may corroborate the 
study findings of Nozaki et al. Age and gender are predictors to medication nonadherence 
using the alpha value of 0.05. The information can assist researchers in deciding the 
importance of the predictor variables of sociodemographics, age, and gender for future 
studies.   
Finding 8: Income, Migrant Worker Status, and Nonadherence 
The combination of income and migrant worker status was not a strong predictor 
of medication nonadherence among Latinos with diabetes Type II. The Logistic 
Regression Omnibus Test of Model Coefficients was (Chi-square = .001; p = .999; OR = 
1.003/1.009).  Based on my experience of working with diabetic patients, I expected that 
patients’ nonadherence to medications would be related to income and migrant worker 
status. However, the study findings showed that the combination of income and migrant 
worker status was not a strong predictor to medication nonadherence. Future studies are 
needed using the combination variables income and migrant worker status. There are 
many other factors that limit income and migrant worker status in maintaining adherence 
to diabetes Type II medications, such as time away from home, values and beliefs about 
nutrition while working, and exposure to health education. 
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Finding 9: Age, Health Education, and Nonadherence 
The combination of age and health education was not a strong predictor of 
medication nonadherence among Latinos with diabetes Type II. The Logistic Regression 
Omnibus Tests of Model Coefficients was calculated an overall (Chi-square = 4.771; p = 
.092; OR =  .912/1.898). There have been no previous studies done that combined 
variables similar to this study to identify strong predictors to medication nonadherence 
among Latinos with diabetes Type II. Therefore, the results of this study may be used for 
future research using the combination variables as used in this study. 
Finding 10: Income, Family Size, and Nonadherence 
There was no association between the combination of income, family size, and 
adherence to medications. The combination of income and family size was not a strong 
predictor of nonadherence to medications among Latinos with diabetes Type II. The 
overall Logistic Regression Omnibus Tests of Model Coefficients yielded a (chi-square = 
1.172; p = .323; OR = .937/1.265). Because the combination variable income and family 
size have not been studied, future research is needed to determine whether family size 
combined with income is a predictor to medication nonadherence among Latinos with 
diabetes Type II. 
Finding 11: Gender, Health Education, and Nonadherence 
The combination of gender and health education was a strong predictor of 
nonadherence to medications among Latinos with diabetes Type II. Because gender and 
health education were strong predictors when they were analyzed individually, it is not 
surprising to see gender and health education combined to be a strong predictor of 
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medication nonadherence among Latinos with diabetes Type II. The overall Logistic 
Regression Omnibus Test of Model Coefficients calculated (chi-square = 11.809; p = 
.003; OR = .420/1.862). Health education should be instructed in a way that meets the 
needs of the individual patient, taking into account the patient’s workplace, work away 
from home, and nutrition while away from home including drinks. Health educators play 
an important role as part of the health care team. Health education should be altered, 
teaching about glucose levels before and after nutrition. Patients should be empowered to 
perform finger sticks at home before and after meals to prevent hypoglycemia and 
hyperglycemia reactions in blood glucose levels. It is worth altering health education to 
make it more appealing for males, while keeping it appealing for females. It is important 
to teach patients how to maintain hydration without the use of alcohol beverages and diet 
using the recommended diet by the American Diabetes Association and the Centers for 
Disease Control and Prevention.   
The data analysis included a descriptive and inferential statistical analysis of the 
association between the independent variables of age, gender, income, migrant worker 
status, family size, health education, and the outcome of medication adherence. I found 
that 93 patients (46.5%) were adherent to medications among Latinos with diabetes Type 
II, and 107 patients (53.5%) were nonadherent to medications among Latinos with 
diabetes Type II. Nonadherence is defined as a prescription or recommendation from a 
clinician not followed by a patient. My findings contradict Parada et al. (2012) who 
demonstrated that, out of 302 patients, 60% of Latinos with diabetes Type II were 
nonadherent to medications. Wabe et al. (2011) indicated that the worldwide adherence 
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rate of diabetes Type II medications was approximately 36% to 93%, depending on the 
demographics and socioeconomic status of the individual. In Fresno County, the 
nonadherence rate was 53.5% for this study, and thus 46.5% of patients who adhered, 
demonstrating a lower adherence rate to medications among Latinos with diabetes Type 
II. Only a few sociodemographics predictors proved to have a strong association to 
medication nonadherence among Latinos with diabetes Type II.     
Limitations of the Study 
One of the original limitations of this study was that some patients may not have 
identified themselves as being Latino; as a result, potential participants may not have 
been included in the study. It was assumed that most Latino subjects did identify 
themselves as Latinos. As the data were gathered, there was no way to determine whether 
or not patients had identified themselves incorrectly; thus, I could not determine whether 
it truly affected the result of this study. 
The study participants were randomly chosen using a random number generator 
from the archived data base. More women than men were selected. Because gender 
proved to be a strong predictor of medication nonadherence among Latinos with diabetes 
Type II, selection bias could have been present secondary to limited access to data. 
Recommendations 
The study results indicated that only gender and health education are strong 
predictors to the outcome dependent variable of adherence. Therefore, further study is 
needed to identify additional variables as possible predictors. It is the responsibility of 
clinicians to teach personalized health education classes. However, it is also the 
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responsibility of the patient to attend health education classes. Hospitals, clinics, as well 
as independent physicians or health educators must follow a protocol of teaching patients 
about diet, alcoholic beverages, exercise, medications, and the effects these have on 
diabetes prevention and management. Health education may assist in increasing 
awareness of self-management.  
Because more females than males were randomly selected for the study, I 
recommend that females and males ought to be studied as separate entities. Additional 
recommended variables may pertain specifically to diet, for example, number of 
alcoholic beverages per week, the number of sodas per week, carbohydrate intake, and 
sugary treats. 
Diabetes Type II is without symptoms with the exception of hyperglycemia 
causing polyuria, polyphagia, and polydypsia. Therefore, the health care team must 
encourage daily glucose testing to allow the patient to know his/her daily glucose level 
and understand the need for medication, diet, and exercise. A proactive approach will 
decrease cultural beliefs relating to causes of diabetes Type II, strengthening the value of 
diabetes Type II self-management. These opportunities will improve adherence to 
medication, promote open communication with the patient’s primary medical provider, 
increase adequate diet and exercise, and maintain regular appointments with a medical 
provider. 
Implications to Social Change 
Swan (2010) explained that helping patients understand their barriers to diabetes 
management is important in preventing the same barriers. Understanding why patients are 
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not able to self-manage their diabetes is important for the patient, the family, and the 
health care provider.  Decreasing cost and complications and improving quality of life 
and patient satisfaction for both males and females is important to stockholders that 
finance health care for the uninsured, insurance payers, and the country, including 
patients and families. Disease awareness and adherences to medications with diabetes 
Type II among Latinos will decrease complications such as retinopathy, peripheral 
neuropathy, kidney disease, coronary artery disease, and depression.  Adherence to 
medications prevents premature deaths, preserves body image, improves well being, and 
increases family, patient social satisfaction.  Adherence to medications improves the 
patients psychological well being and it empowers the patient to self-mange his/her 
diabetes type II a chronic disease. 
The findings of this study could assist in changing or improving national policies 
in relation to self-management of Latinos with diabetes Type II. Health education, 
reading materials, or videos should be provided in areas such as waiting rooms. 
Incentives such as t-shirts or coupons may be offered to patients as a way to bring them 
into health education classes. Physicians should be persuaded to offer summarized 
recommendations or to push for patients to take more health education classes. Funds 
may be considered through grants in order to promote diabetes Type II health education 
awareness through the media on a regular basis or in the weekly newspaper. 
Conclusion  
 I found that only 46.5% of Latino patients receiving treatment in the community 
clinic in Fresno County California adhered to medications (chi-square = 7.734; p = .005). 
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It is important to reach out to physicians, nurses, health educators, nutritionists, and other 
health care providers across the country with significant predictors of diabetes Type II 
medication nonadherence to prevent complications and to start early intervention because 
they are gateways to their communities. Physicians play a key role in promoting diabetes 
Type II awareness and health education referrals because patients have closer 
relationships with their physicians. Thus, patients are more likely to adhere to 
recommendations given by their physicians rather than from other sources. Family 
members of patients with diabetes Type II also need to be made aware of the implications 
of diabetes Type II so that they may reach out and suggest lifestyle modifications, diet, 
and exercise. Patient awareness can be increased through accountability to others while at 
the same time learning to self-manage diabetes Type II. 
 Migrant worker status requires goal settings for both the health care provider and 
the patient to self-manage his or her diabetes Type II when on the road. Patients need to 
be educated about the self- management of his or her medication by mouth and how to 
inject insulin. Learning how to prevent hypoglycemia reactions when working on the 
field or when on the road is an important step in patients taking responsibility for their 
diabetes Type II management. Blood glucose testing is important and knowing how to 
interpret and respond to the blood glucose findings. It is important to get the family 
involved in the self-care of the patient, including diet and exercise 
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 BIANCA L. TRISTAN—RN, CCRN, FNP, MSN 
 
 
 
SKILLS/DUTIES________________________________________________________ 
 
 Responsible for patient management, including physical diagnosis and psycho-
social assessment in primary health care. 
 Skilled in triage, lacerations and assisting the ER physicians with critical care 
conditions. 
 Specialized in women’s health, provided care prenatal, family planning, and GYN 
preventive. 
 Have written and instituted protocols for Phase I Cardiac Rehabilitation 
 Provided leadership for a 43-bed telemetry unit 
 Responsible for annual budget 
 Implemented JCHO guidelines and 24-hour unit accountability 
 Provided care for critically ill patients, which included hemodynamic monitoring, 
ICP monitoring, PCA pumps, vasoactive drugs, vascular condition, ventilation, 
and assessment. 
 Monitored acute seizure disorders, head trauma, and dilantin research for patients 
with head trauma. 
 Provided telemetry nursing.  Responsible for supervising and scheduling 25 
professionals and directing shift unit operations and functions. 
 Provided patient care, including monitoring fluid and electrolyte imbalances, 
physical assessments and interventions. 
 
 
PROFESSIONAL EXPERIENCE________________________________________ 
 
2008 to Present Clinica Sierra Vista Family Nurse Practitioner no, CA 
2004 to 2008 Sequoia Community Health Center Family Nurse Practitioner o, CA 
2002 to 2004 Good Sam Hospital Family Nurse Practitioner                                                 
  (ER) 
2002 to 2004 San Judas Medical Center Family Nurse Practitioner , CA 
2001 to 2002 LAC/USC County Hospital Family Nurse Practitioner , CA 
1998 to 2001 Community Health Foundation Family Nurse Practitioner , CA 
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1996 to 2003 Robert F. Kennedy Hospital CHW Administrative            
  Supervisor 
1993 to 1997 Charter Community Hospital Cardiac Nurse Rehabilitation  
  Coordinator 
1991 to 1997 Charter Community Hospital Nurse Manager Definitive , CA 
  Observation Unit; Nursing 
Supervisor 
1987 to 1989 White Memorial Medical Center Staff Nurse—Intensive Care , CA 
1987 to 1988 Kings Drew Medical University Double-Blinded Research       
 Nurse 
1983 to 1987 White Memorial Medical Center Charge Nurse—Definitive         
  Observation Unit 
1981 to 1983 White Memorial Medical Center Staff Nurse—                               
 Medical/Surgical 
  Orthopedic; Pediatrics 
 
EDUCATION___________________________________________________________ 
 
Presently Walden University Online 
 PhD—Public Health, Epidemiology  
 
1997 to 1998 CA State University, Dominguez Hills n, CA 
 Post-Master’s Degree—Family Nurse Practitioner  
 
1994 to 1996 University of Phoenix , CA 
 Master’s Degree—Nursing Administration 
 
1987 to 1988 Pacific Union College in, CA 
 Bachelor’s Degree—Nursing, PHN Certificate 
 
1982 to 1985 Compton Community College ton, CA 
 Associate’s Degree—Nursing 
 
1978 to 1980 Compton Community College ton, CA 
 Licensed Vocational Nurse 
 
 
 
 
 
124 
 
 
LICENSURE/CREDENTIALS____________________________________________ 
 
 ANCC Certified 
 Family Nurse Practitioner 
 CA Registered Nurse' 
 American Heart Association Advanced Cardiac Life Support  
 Certified 
 American Red Cross Disaster Health Nurse 
 State of CA Certified Public Health Nurse 
 
 
PROFESSIONAL ORGANIZATIONS______________________________________ 
 
 American Academy of Nurse Practitioners; active member since                      
2000 
 American Nurses Association; active member since 1998 
 American Association of Critical Care Nurses; active member 
 since 1986 
 
 
OTHER DATA__________________________________________________________ 
 
 Verbal and written fluency in Spanish 
 References available upon request 
 
 
 
 
 
 
 
 
 
 
 
 
